Express Healthcare (Vol. 16, No. 12) January 2024

VOL.16 NO 12 PAGES 48

www.expresshealthcare.in

RADIOLOGY & IMAGING Advancements in radiology and imaging: Transforming healthcare delivery

INSURANCE

INDIA'S FOREMOST HEALTHCARE MAGAZINE SINCE 2000

JANUARY 2024, `50

Healthcare financing: Prescription for India's healthcare delivery revolution

3.6+DR 3 6+DR

5.0 DR

Series : DR-1

*Also have X-ray range of products

We are Ultrasound Professionals

ISO 13485:2016 CERTIFIED COMPANY ISO 9001:2015 CERTIFIED COMPANY

BPL MEDICAL TECHNOLOGIES PRIVATE LIMITED Regd. Office: 11th KM, Bannerghatta Road, Arakere, Bangalore-560076, Karnataka, India.

Website: www.bplmedicaltechnologies.com Toll Free: 1800-4252355 For Enquiries: sales.medical@bpl.in CIN: U33110KA2012PTC067282

ALPINION MEDICAL SYSTEMS CO., LTD. 15,Magokjungang14-ro,Gangseo-gu,Seoul,RepublicofKorea

Homepage www.alpinion.com E-mail interna�onal@alpinion.com TEL +82-2-3282-0900 FAX +82-2-851-5593 Copyright©2023 ALPINION MEDICAL SYSTEMS CO., LTD. All rights reserved.

Follow us @bplmedtech 2023

©2023 BPL Medical Technologies Private Limited. All rights reserved. BPL Medical Technologies Private Limited & Alpinion Medical System reserves the right to make changes in product features, specifications, aesthetics and/or to discontinue the same at any time without notice or obligation

BPL XCUBE90 PAD 20:12:23

Revealing the Unseen:

Diagnose with confidence, Clear, Accurate and Comfortable

CLARITY 1.5

16 Ch MRI Scanner with MUSIC 66 X 16 and All Application A

Sequoia Healthcare Private Limited, Plot No 27, Survey No 125, KIADB Industrial Area, Chikkaballapur, Karnataka, INDIA-562101

www.sqhpl.com

084319

Revealing the Unseen:

qīÐÆðĮðďĊ ðĉ­æðĊæș ­ĮĮķīÐÌ ăďĊæÐŒðĴř

INSPIRATION 64 • 75cm Gantry Aperture • Smart Workflow • HD Imaging • New Detector Design • Excellent Iodine Contrast • Range of Application • Couch up/down • 0.7 sec. Rotation Time • Choice of X-ray Tube 2/3.3 MHu • 45 deg. Digital Tilt

20843

sales@sqhpl.com

Building No.1, District No.7, URANUS Avenue, AMTZ Campus, Near Pragati Maidan, VM Steel Projects, S.O. Visakhapatnam - 530031

DIAGNOSTICS

START-UP

12

19

CONTENTS HEALTHCARE IT

Chairman of the Board Viveck Goenka Sr. Vice President-BPD Neil Viegas Vice President-BPD Harit Mohanty Editor Viveka Roychowdhury* Editorial Team Lakshmipriya Nair Kalyani Sharma DESIGN Art Director Pravin Temble

DIAGNOSTIC SECTOR IS UNDERGOING PARADIGM SHIFT DRIVEN BY TECHNOLOGICAL ADVANCEMENTS

RADIOLOGY & IMAGING

Senior Designer Rekha Bisht

PROMISING FUTURE OF INDIAN HEALTH STARTUPS IN THE GUT MICROBIOTA DOMAIN

20

SOLVING INDIA'S HEALTHCARE ACCESSIBILITY PUZZLE WITH AI IN 2024

HOSPITAL INSURANCE INFRASTRUCTURE

HEALTHCARE TRACKER

Senior Artist Rakesh Sharma Marketing Team Rajesh Bhatkal Ashish Rampure Debnarayan Dutta Production Co-ordinator Dhananjay Nidre Scheduling & Coordination Pushkar Waralikar CIRCULATION Mohan Varadkar

24

ADVANCEMENTS IN RADIOLOGY AND IMAGING: TRANSFORMING HEALTHCARE DELIVERY

26

PROVIDING MORE ‘HOSPITALITYORIENTED ENVIRONMENT’ FOR PATIENTS THAN ‘HOSPITAL ORIENTED’

28

HEALTHCARE FINANCING: PRESCRIPTION FOR INDIA'S HEALTHCARE DELIVERY REVOLUTION

P35: INTERVIEW CHAITANYA SARAWATE Managing Director, Wipro GE Healthcare

Express Healthcare® Regd. With RNI No.MAHENG/2007/22045. Postal Regd.No.MCS/162/2022 - 24. Printed and Published by Vaidehi Thakar on behalf of The Indian Express (P) Limited and Printed at The Indian Express Press, Plot No.EL-208, TTC Industrial Area, Mahape, Navi Mumbai-400710 and Published at Mafatlal Centre, 7th floor, Ramnath Goenka Marg, Nariman Point, Mumbai 400021.

Editor: Viveka Roychowdhury.* (Editorial & Administrative Offices: Mafatlal Centre, 7th floor, Ramnath Goenka Marg, Nariman Point, Mumbai 400021) * Responsible for selection of news under the PRB Act. Copyright © 2017. The Indian Express (P) Ltd. All rights reserved throughout the world.

Reproduction in any manner, electronic or otherwise, in whole or in part, without prior written permission is prohibited.

EXPRESS HEALTHCARE

9

January 2024

EDITOR’S NOTE

Plugging the gaps in healthcare policy

I

f 2023 was a year of tentatively putting COVID on the back burner to re-focus on pending infrastructure updates, 2024 will probably be more of the same. On the policy front, key regulatory changes could make or mar the sector. Achieving the perfect balance between the interests of various stakeholders will continue to be a major challenge.

Unfortunately, COVID is not completely out of the picture. The WHO Director-General Dr Tedros Adhanom Ghebreyesus declared an end to COVID-19 as a public health emergency of international concern in May 2023. But by the end of the year, the latest COVID variant, JN.1, has caused a spike in COVID cases, in certain countries, including India. The Ministry of Health & Family Welfare stepped up surveillance and advised hospitals to keep beds, ventilators etc ready but for now, the situation seems under control.

Analysts seem confident the sector will clock a decent year of steady revenues. Kinjal Shah, Vice President & Co-Group Head - Corporate Ratings, ICRA expects the performance of the Indian hospital industry to remain strong in FY2024, on the back of healthy occupancy and strong ARPOB levels. ICRA expects occupancy of its sample set to remain flattish at 64-65 per cent in FY2024, while the ARPOB is expected to expand by 8-9 per cent.The sector is expected to reap the benefits of various measures. As Shah points out, “Benefits from improving scale, cost optimisation efforts, steady demand for marginaccretive elective procedures, and improving case and payor mix in addition to healthy international patient footfalls will support operating profit margins (OPM) of over 22-23 per cent for the sample set companies in FY2024 as compared to 22.6 per cent in FY2023.

Further, given the healthy accruals and low debt levels, debt metrics for the sample set companies are expected to remain strong in FY2024 despite ongoing capital expenditure towards capacity expansion. Thus, ICRA continues to have a stable outlook on the Indian hospital industry.”

A recent report from Jeffries also picked India's hospital sector as a top growth sector, with a projected 3-10 per cent rise in net income from FY24-26, as significant capacity expansion over the next 12 -15 months reaches a critical break even point. Thus it is no wonder that 2023 saw PE/VC funds increasing investments in India’s hospital segment.

The country's medical devices also saw a ‘recordbreaking surge’ of $464 million in foreign investments in medtech in the first three quarters, as per the Medical Technology Association of India (MTaI). As Pavan Choudary, Chairman, MTaI puts it, “MTaI member companies supply nearly 80 per cent of the critical care medical devices and account for 70 per cent of the overall medical device market share.

10 EXPRESS HEALTHCARE January 2024

On the policy front, key regulatory changes could make or mar the sector. Achieving the perfect balance between the interests of various stakeholders will continue to be a major challenge

Through its members’ investments in manufacturing, R&D and Healthcare worker training it has served the Indian patient while at the same time creating most of the market that exists in the country today. MTaI members are also responsible for bringing a large portion of the investment in this sector through FDI.” But will increasing FDI suppress the domestic medical devices sector and the hope for indigenous more affordable medical devices? The fault lines between the two sides are sure to be more visible as policy makers try to update current regulations. For instance, the passage of the new Drugs, Cosmetics & Medical Device Bill, 2023 through Parliament promises to test the balancing prowess of policy makers. Domestic medical device manufacturers, under the aegis of the Association of Indian Medical Device Industry (AIMED) pointed out the need to have a separate regulatory process for medical devices, while their global counterparts seem fine with the status quo.

Listing the significant difference between drugs/medicines and medical devices, AIMED Forum Coordinator Rajiv Nath reasoned that medical electronic devices are like engineering products like cars, and therefore cannot be manufactured or regulated like drugs. In addition, they need to be stored, transported, installed, and maintained and regularly calibrated to ensure patient safety for the lifecycle of the product. While a separate cadre of qualified regulators for the medical device sector would be ideal, the dearth of inspectors is a major stumbling block. Policy makers need to address the legitimate concerns of patient groups and local medical device makers before the new Drugs, Cosmetics & Medical Device Bill, 2023 is implemented.

The recent launch of the National Single Window System (NSWS) Portal by the CDSCO, is another recent regulatory reform. While Nath appreciates that the NSWS portal could streamline certain applications for drugs and the import and manufacturing of medical devices, he points out that its success will lie in the on-boarding of the various other ministries and regulators at both the central and state levels.

According to Nath, a manufacturer currently needs to apply for over 35 approvals to set up a greenfield medical devices factory in Haryana state. If implemented appropriately, the NSWS portal will reduce transaction time but will it turn out to merely be old wine in a new bottle? With general elections scheduled later this year, let's hope 2024 will be more than just pre election rhetoric.

VIVEKA ROYCHOWDHURY, Editor viveka.r@expressindia.com viveka.roy3@gmail.com

DIAGNOSTICS

Diagnostic sector is undergoing paradigm shift driven by technological advancements Dr Avinash Pahdke, President, Agilus talks about key trends and developments that are poised to reshape the landscape of diagnostic healthcare

I

n the wake of the postCOVID era, customers are seeking greater convenience with home collection services, a seamless digital ecosystem, and reduced turnaround times (TAT). Consequently, there's a notable trend towards the fusion of avant-garde technology in testing procedures and service delivery. This integration aims to elevate precision, expedite processes, and elevate the overall customer experience, aligning with the evolving expectations of a rapidly changing landscape in healthcare. This year, several key trends and developments are poised to reshape the landscape of diagnostic healthcare. ◆ Artificial Intelligence (AI)-powered diagnostics: AI continues to revolutionise diagnostics, offering advanced algorithms capable of analysing vast amounts of medical data. Machine learning models aid in disease detection, prediction, and personalised treatment recommendations. AI-enabled imaging tools, such as radiology and pathology AI, enhance accuracy and speed in diagnosing conditions like cancers and neurological disorders. ◆ Point-of-Care Testing (POCT): The demand for rapid and convenient diagnostic tests at the point of care is on the rise. POCT devices allow for immediate results without the need for extensive laboratory infrastructure.

From glucose monitoring for diabetic patients to infectious disease testing, these portable devices empower healthcare providers to make prompt decisions, especially in remote or resource-limited settings. ◆ Telemedicine and remote monitoring: The integration

12

EXPRESS HEALTHCARE

January 2024

This year holds promise for further innovations that will revolutionise diagnostics, fostering precision, accessibility, and efficiency in healthcare services of telemedicine platforms and remote monitoring technologies has expanded access to diagnostic services. Patients can now undergo preliminary assessments and consultations remotely, reducing the burden on healthcare facilities. Wearable devices and mobile applications enable continuous monitoring of vital signs and health parameters, facilitating early detection of potential health issues. ◆ Genomic diagnostics: Advancements in genomic sequencing technologies have

unlocked new possibilities in diagnostics and personalized medicine. Next-generation sequencing techniques help identify genetic predispositions to diseases, enabling tailored treatment plans and predictive diagnostics for various conditions, including cancer, rare diseases, and genetic disorders. ◆ Digital health records and interoperability: The transition towards comprehensive digital health records and improved interoperability among healthcare systems

fosters seamless sharing of patient data. Integrated electronic health records streamline diagnostic processes, allowing healthcare professionals to access critical information promptly and make well-informed decisions. ◆ Immunodiagnostics and biomarker discovery: Immunodiagnostics and biomarker research are expanding the horizons of diagnostic capabilities. Biomarkers, indicative of specific diseases or physiological conditions, aid in early detection and moni-

toring of diseases. Advancements in immunoassays and biomarker discovery pave the way for more accurate and targeted diagnostic tools. ◆ Augmented Reality (AR) and Virtual Reality (VR) in training and diagnostics: AR and VR technologies are increasingly employed in diagnostic training and simulations. Medical professionals utilise these immersive technologies to enhance their diagnostic skills through lifelike scenarios and interactive learning modules, ultimately improving accuracy in diagnosis and treatment. ◆ Ethical and regulatory considerations: With the proliferation of innovative diagnostic technologies, there arises a need for robust ethical frameworks and regulatory guidelines. Ensuring patient privacy, data security, and ethical use of AI in diagnostics remain pivotal in maintaining trust and upholding standards in healthcare.

In conclusion, the diagnostic healthcare sector is undergoing a paradigm shift, driven by technological advancements and a focus on patientcentric care. This year holds promise for further innovations that will revolutionise diagnostics, fostering precision, accessibility, and efficiency in healthcare services. However, alongside these advancements, it is crucial to address ethical concerns and regulatory challenges to ensure the responsible and equitable deployment of these transformative technologies. As we embrace these trends, the future of diagnostic healthcare appears brighter, offering new avenues for early detection, precise treatment, and improved patient outcomes.

AI is expected to play much bigger role in diagnostic testing and reporting A Ganesan, Vice Chairman, Neuberg Diagnostics discusses some of the changes sweeping through the healthcare sector, particularly the diagnostic sector

Scan t o wat ch t he t ut o ri al

INDIA’S MOST TRUSTED BRAND

T

he healthcare sector including diagnostic industry is going through constant technology changes and the industry must be conscious of these changes and continuously update themselves to remain competitive. Some of the changes sweeping through the healthcare sector, particularly the diagnostic sector is discussed here.

PROMOTING PATIENT SAFETY

AVAI A VA LABLE IN 31G G & 32 G

Home healthcare The home collection of body samples is catching up very fast and patients are now very comfortable getting themselves tested at home. Most players offer blood collection @home at no extra cost, and this has become a boon as far as patients are concerned. In recent years tests such as ECG and ultrasound are made available at home, and this will only increase in the near future.

Teleradiology/ telepatholgy Experienced radiologists and

EXPRESS HEALTHCARE

13

January 2024

Precision, P ii EEngineered, i d Aff Affordable d & EEasy tto Use. www.hmdhealthcare.com

info@hmdhealthcare.com

DIAGNOSTICS pathologists are in short supply in India and teleradiology and telepatholgy plays a big role in interpretation of images as well as body specimens. Teleradiology and telepathology also plays a big role in getting second opinions which will help clinicians in better management of diseases.

Artificial Intelligence (AI) driven tools Like any other sector AI will play a big role in diagnostic testing and solutions as well.

AI systems can help healthcare practitioner diagnose diseases based medical images. It has been reported recently that meta-analysis has proven that diagnostic performance of deep learning AI tool was equivalent to that of highly trained healthcare professional. In future, AI is expected to play a much bigger role in diagnostic testing and reporting.

Point of care testing (POCT) New technologies being developed allow testing near the patients, including their homes and offices. This helps in travel time and increased comfort to the patients.

These new technologies include handheld testing equipment, handheld Kiosks and digital transmission of data, which helps in on the spot di-

Labs and clinicians are constantly seeking to reduce the number of tests that are required so that the patient gets enhanced value at lesser/optimum cost agnosis and solution. This also helps in digitisation and storage of patient data which will be available to the clinicians and patients at the touch of a button.

Predictive analysis Genetic testing using body samples like blood, skin, hair etc will play a big role in preventive medicine in the years to come. Genome testing will be able to identify future risk of serious diseases including Cardiac diseases, cancer etc.

The potential is enormous as tests can identify mutations that increase the risk of genetic disorders, and most times will be a lifesaving solution for the customers.

tests, but at the same time do not compromise on patient wellbeing.

Real time diagnosis There is an explosion of wearable devices in the market from watches, rings, patches, bandages, spectacles, clothing etc These wearables are able to collect real time health data such as Pulse rate, Blood pressure, sugar fluctuation, respiratory condition etc and give alerts to the patients and clinicians in real time. These devices capture much more data as compared to traditional testing and will be very useful to clinicians in decision making.

Challenges faced by dignostic industry

Lab optimisation solutions Labs and clinicians are constantly seeking to reduce the number of tests that are required so that the patient gets enhanced value at lesser/optimum cost. This analytical tool can analyse vast amount of test results and help lab managers to identify unnecessary

◆ Diagnostic industry is mostly unregulated. There is no entry barrier in terms of approvals accreditation, funding etc. As a result, the organised market is not even 25 per cent of the total market. This has resulted in the proliferation of smaller labs with no regulations as re-

gards quality control and other standards. Industry expects central and state governments to prescribe certain minimum quality standards and accreditation requirements for establishing and running Diagnostic centers.

Such regulatory requirements can be implemented in phased manner so as not impact the lives of many of the small lab business. ◆ Healthcare services are not subject to GST, though almost all input costs suffer GST. Perhaps government thought process is levy of GST will be unpopular. On the contrary, levy of GST on healthcare services will benefit the consumers as this will bring down the cost of operations, which can be passed on to the consumers. ◆ In case government is not inclined to levy GST on healthcare services, certain specific input materials/services specifically used by healthcare can be exempted from GST or rates brought down to the lowest slab. ◆ Despite significant techno-

logical advancements in curative as well as preventive diagnostics, our vast rural population is still not able to access such technologies for two reasons: lack of infrastructure and cost of such tests. Government support in extending such facilities to our rural population, whether through its own PHC s are through large chain of labs through PPP model will immensely benefit rural population. ◆ Tamil Nadu and few more states have implemented free healthcare services to poor people and those schemes only cover hospitalisation for decease management. The Scheme may also cover wellness programmes/ basic screening (at least once in two / three years), so that deceases can be identified and treated well in advance. This might bring down the cost of healthcare support as treatment in initial stages will be less expensive. ◆ Government gives certain Income tax benefits for wellness checks, but the amount eligible for such exemption is very meagre at Rs 5000. The limit may be increased to Rs 15,000 to encourage people to go for annual medical checks once in a year. Such exemption may be extended to only people above 40 years as those are the age groups who are prone to diseases.

CONTRIBUTOR’S CHECKLIST ● Express Healthcare accepts editorial material for the regular columns and from pre-approved contributors/columnists. ● Express Healthcare has a strict non-tolerance policy towards plagiarism and will blacklist all authors found to have used/referred to previously published material in any form, without giving due credit in the industry-accepted format. ● As per our organisation’s guidelines, we need to keep on record a signed and dated declaration from the author that the article is authored by him/her/them, that it is his/her/their original work, and that all references have been quoted in full where necessary or due acknowledgement has been given. The declaration also needs to state that the article has not been published before and there exist no impediment to our publication. Without this declaration we cannot proceed. ● If the article/column is not an original piece of work, the author/s will bear the onus of taking permission for re-publishing in Express Healthcare. The final decision to carry such republished articles rests with the Editor. ● Express Healthcare’s prime audience is senior management and professionals in the hospital industry.

Editorial material addressing this audience would be given preference.

14 EXPRESS HEALTHCARE January 2024

● The articles should cover technology and policy trends and business related discussions. ● Articles by columnists should talk about concepts or trends without being too company or product specific. ● Article length for regular columns: Between 1300 - 1500 words. These should be accompanied by diagrams, illustrations, tables and photographs, wherever relevant. ● We welcome information on new products and services introduced by your organisation for our Products sections. Related photographs and brochures must accompany the information. ● Besides the regular columns, each issue will have a special focus on a specific topic of relevance to the Indian market. You may write to the Editor for more details of the schedule. ● In e-mail communications, avoid large document attachments (above 1MB) as far as possible. ● Articles may be edited for brevity, style, relevance. ● Do specify name, designation, company name, department and e-mail address for feedback, in the article. ● We encourage authors to send a short profile of professional achievements and a recent photograph, preferably in colour, high resolution with a good contrast.

Email your contribution to: viveka.r@expressindia.com viveka.roy3@gmail.com Editor, Express Healthcare

DIAGNOSTICS

Advancing healthcare horizons: Emerging trends in diagnostics Dr Dinesh Chauhan, CEO, CORE Diagnostics share his insights on latest developments and upcoming trends in diagnostics

A

s the healthcare sector stands on the cusp of a transformative year marked by technological advancements and evolving challenges, the diagnostics landscape plays a pivotal role in shaping the future of patient care.

Machines take the helm: Artificial Intelligence (AI) and Machine Learning (ML) redefining diagnostics Gone are the days when AI and ML were merely buzzwords in healthcare. Today, they are actively transforming the diagnostic landscape. Imagine AIpowered tools scrutinising mammograms with eagle eyes, identifying even the subtlest signs of malignancy with remarkable accuracy. Or, ML algorithms gleaning insights from vast medical data sets, uncovering hidden patterns that predict disease progression and personalise treatment plans. This potent synergy between human expertise and machine intelligence is ushering in a new era of data-driven, precise diagnostics.

Beyond the confines of labs: Point-of-Care (POC) testing democratises diagnostics Picture a world where critical tests can be performed not just in sterile labs, but at the patient's bedside, in remote clinics, or even in the comfort of their own homes. POC testing is making this vision a reality.

Handheld devices are analysing blood samples for a multitude of biomarkers, offering instant results and empowering rapid clinical decisionmaking. This is particularly transformative for underserved communities, bringing

future of personalised medicine. We are now identifying mutations linked to cancer, heart disease, and neurological disorders, enabling proactive interventions and targeted therapies. NGS is not just a diagnostic tool, it's a key that unlocks the door to preventative healthcare.

Wearables and sensors: Turning our bodies into data powerhouses

Picture a world where critical tests can be performed not just in sterile labs, but at the patient's bedside, in remote clinics, or even in the comfort of their own homes. POC testing is making this vision a reality life-saving diagnostics closer to those who need it most.

Unlocking the secrets of life: Next-Generation Sequencing (NGS) reshapes genetics NGS is no longer a futuristic

technology confined to research labs. It is now accessible and affordable, allowing us to map an individual's entire genome in record time. This is unlocking the mysteries of genetic predisposition to diseases, paving the way for a

Tiny, unobtrusive devices are becoming extensions of ourselves, continuously monitoring our vital signs, sleep patterns, and even emotional states. This continuous stream of data is a goldmine for diagnostics, enabling remote monitoring of chronic conditions, detecting subtle physiological changes that predict disease onset, and even offering realtime feedback to guide lifestyle modifications. Wearables are not just fitness trackers; they are silent guardians of our health.

Big data demystified: Transforming chaos into clarity The healthcare industry sits

on a mountain of data, but harnessing its true potential has been a challenge. Enter Big Data analytics. Advanced algorithms are now sifting through this ocean of information, identifying trends, correlations, and hidden patterns that were previously invisible. This is enabling the development of predictive models, optimising resource allocation, and even personalising public health interventions. Big Data is not just about numbers, it's about unlocking the collective wisdom of healthcare data for the greater good.

Challenges and the road ahead While these trends are undeniably exciting, challenges remain. Regulatory hurdles, ethical considerations surrounding data privacy, and ensuring equitable access to these technologies are all roadblocks to overcome. Collaboration between industry, academia, and policymakers is crucial to navigate these complexities and ensure that these advancements reach those who need them most.

EXPRESS HEALTHCARE

15

January 2024

DIAGNOSTICS

IHE is emerging as a new vision for the future of healthcare Dipanngshu Sannyal, Chief Business Officer, Oncquest Labs emphasises that the future of IHE will transform healthcare into a smart system

T

he medical diagnostic industry is a rapidly growing sub-sector of the healthcare sector, focusing on improving patient care, increasing healthcare efficiency, and creating equity.

Medical devices encompass various physical and digital technologies used to treat, prevent, diagnose, mitigate, or cure diseases. The recent boom in the medical device market can be attributed to the 2020 global pandemic, which initially impacted the industry due to supply chain disruptions and reduced product innovation budgets.

However, the pandemic has accelerated growth in this space, with the trend expected to continue in the future. The pandemic highlighted the medical device industry's potential for improving patient outcomes and healthcare processes. The market is expected to grow, with global revenue of $595 billion in 2024 and a CAGR of 6.1 per cent from 2022 to 2030, making it a high-demand investment sector.

The Intelligent Health Ecosystem (IHE) is emerging as a new vision for the future of healthcare, driven by the convergence of technological advancements and personalised care demands.

Diagnostic trends to look for in 2024 ◆ Smart connectivity The future of IHE will transform healthcare into a smart system, requiring a comprehensive ecosystem to connect data to clinicians and patients, enabling personalised, real-time detection, prediction, and intervention, rather than a lack of data. The intersection of diagnostic technologies and smart connectivity has led to the development of innovative solutions that enhance the speed, accuracy, and accessibility of medical

16 EXPRESS HEALTHCARE January 2024

The future of IHE will transform healthcare into a smart system, requiring a comprehensive ecosystem to connect data to clinicians and patients, enabling personalised, real-time detection, prediction, and intervention, rather than a lack of data diagnostics. IoT enables remote monitoring of patients, allowing real-time data collection and transmission of vital signs or diagnostic information to healthcare providers.

This is particularly valuable for managing chronic conditions and ensuring timely intervention.

Smart connectivity facilitates virtual consultations, enabling healthcare professionals to remotely assess and diagnose patients. This is especially useful for minor ailments, follow-up visits, or initial assessments. Connectivity

allows medical images, such as X-rays, MRIs, and CT scans, to be transmitted securely for remote analysis.

This enables faster diagnosis and consultation with specialists, regardless of geographical location. Also, Smart connectivity enables the aggregation and analysis of large datasets, fostering the development of AI algorithms for diagnostic purposes. AI can assist in pattern recognition, early detection of diseases, and personalised medicine. ◆ Telehealth

The COVID-19 pandemic and regulatory response have accelerated telehealth access, prompting Medtechs to adapt to changes in care channels.

Hybrid care, combining inperson and virtual care, is still happening. Further progress will require reassessing workplace roles, redesigning payment incentives, and considering digital command centers for clinicians to monitor data and coordinate care at home. Hybrid care, if overcome, can enhance costs and patient outcomes by opening hospital beds and staff. By evolving care models, designing with consumer and clinicians in mind, and partnering with stakeholders like health organisations, retailers, governments, community organisations, and ambulatory surgical centers, it can expand outpatient settings. ◆ Home diagnostics Some of the major trends to look for in home diagnostics include wearable health devices, telehealth and remote monitoring, at-home testing kits, digital health apps, genetic testing, smart heath appliances, point-ofcare diagnostics, AI-powered diagnostics, augmented reality for guidance, and behavioral health monitoring. With several disrupting technological advancements, Artificial Intelligence (AI) is being incorporated into home diagnostics to assist with the interpretation of test results, symptom analysis, and personalised health recommendations. Also, some home diagnostics devices utilize augmented reality to guide users through sample collection or testing processes, ensuring accuracy and reliability. With the increase in home diagnostics, there is a growing focus on ensuring the privacy and security of health data and companies are implementing robust measures to protect sensitive information.

◆ AI/ Machine Learning (ML) Medtechs are grappling with the potential and repercussions of large language models (LLMs). AI could improve content creation, clinical documentation, and clinician-patient interaction notes, leading to more value-added interactions. AI adoption in commercial operations can also enhance direct-to-patient communication, particularly in hospitals facing staffing shortfalls and burnout. AI can also create novel medical device designs. A 3D generative AI model can create design prototypes, possibly personalising them based on inputs.

It's crucial for medtechs to understand that AI is not a standalone solution but contributes to the effectiveness of other digital offerings, medical device software, and machine learning models.

However, there still remain certain challenges to be addressed Laboratories are facing a severe shortage of medical laboratory professionals due to factors like training program closures, decreased student applicants, and financial constraints. Laboratories must focus on competitive compensation, fostering a positive work culture, and offering career advancement opportunities to address the shortage of skilled staff and meet the increasing demand for laboratory testing. While shortage for skilled diagnostic professionals remains, it should be noted that automation and informatics are crucial in clinical labs, especially in the face of staffing shortages. Implementing automation and interconnected workflows from pre-analytical to testing and result reporting can improve efficiency, allowing laborators to focus on complex tasks and lessen the burden of manual processes.

DIAGNOSTICS

Diagnostics: The future of growing healthcare landscape in India Manav Teli, MD, LordsMed highlights that in the realm of diagnostics for the year 2024, pivotal trends are reshaping the industry landscape. The foremost among these is the discreet infusion of artificial intelligence into diagnostic protocols

I

n the fast-paced world of healthcare, accessibility is a cornerstone of effective patient care. As we navigate the challenges of providing timely and accurate diagnostics, the spotlight increasingly turns towards enhancing point-of-care diagnostics. The POC testing was first introduced in 1962 with the development of a method for rapid analysis of blood glucose, and shortly after in 1977, rapid pregnancy tests were developed that pioneered a trend for personalised diagnostics.

These developments introduced POC testing and devices to clinical settings and laboratories around the globe that changed the diagnostics field tremendously. As we step into 2024, several trends are set to reshape the diagnostics industry, influencing the way we detect and manage diseases.

From innovative technologies to a renewed focus on data integration.

Market potential Country has a huge resource gap of over 4 million health workers; nearly 60 per cent of the existing personnel work in urban areas, whereas 70 per cent of the Indian population lives in rural areas but as POC diagnostic devices are being used as a preliminary step in clinical diagnosis it has helped in the reduction of burden on advanced medical ecosystems.

The current POC market is dominated by glucose, cardiac, and pregnancy testing, and represents a very rapid-growing worldwide. According to recent report the clinical diagnostic market is expected to reach USD 72.0 billion by 2027 from an estimated USD 43.2 billion in 2022, at a CAGR of 10.8 per cent from 2022 to

efficient data management, and improved accessibility. Finally, the discreet expansion of genomic medicine applications underscores a shift toward a more personalised diagnostics approach. In 2024, the diagnostics industry will undergo a nuanced transformation, quietly paving the way for a future marked by enhanced precision, accessibility, and personalized care.

Key advantage of POC in medical testing

2027. The COVID-19 outbreak has further accelerated the global demand for diagnostic kits to rapidly detect the disease. Therefore, India provides a huge market potential for POC diagnostic devices industries to progress and fulfil the healthcare demand of the large population.

Trends in diagnostics in 2024 In the realm of diagnostics for the year 2024, pivotal trends are reshaping the industry landscape. The foremost among these is the discreet infusion of Artificial Intelligence (AI) into diagnostic protocols.

This subtle integration of advanced algorithms is quietly but profoundly elevating diagnostic accuracy, accelerating processes, and offering in-

depth insights. It stands as a testament to the silent revolution occurring in the detection and analysis of medical conditions.

Another understated yet impactful is the escalating prominence of point-of-care testing. Operating subtly at the nexus of immediacy and accuracy, this trend underscores the industry's commitment to delivering swift, precise diagnostic results. On the other hand, the quiet evolution of liquid biopsy technology is gaining momentum and redefining diagnostic methodologies. Its non-invasive nature not only transforms disease detection but also enhances patient experiences. The collaboration between diagnostics and digital health platforms is fostering seamless communication,

Enhanced point-of-care diagnostics provide swift and crucial results, significantly improving healthcare decision-making in time-sensitive scenarios. Whether conducting rapid tests for infectious diseases or monitoring chronic conditions on the spot, these diagnostics empower healthcare professionals to make informed decisions promptly, ultimately enhancing patient outcomes. Their accessibility extends across diverse healthcare settings, including primary care clinics, emergency rooms, and home healthcare scenarios, allowing patients to benefit from immediate diagnostics without enduring prolonged waiting times. This fosters a patientcentric approach, encouraging proactive health management.

To unlock the full potential of enhanced point-of-care diagnostics, collaboration is essential. Partnerships between healthcare providers, technology developers, and regulatory bodies play a pivotal role in seamlessly integrating these technologies into existing healthcare systems. Standardisation and interoperability protocols ensure the effective incorporation of data generated at the point of care into

electronic health records, creating a comprehensive and cohesive patient profile.

Challenges in diagnostics While celebrating the strides made in enhancing point-ofcare diagnostics, it is essential to address challenges that may impede their widespread adoption. These include issues related to data privacy, quality assurance, and the need for ongoing training for healthcare professionals. Overcoming these challenges requires a concerted effort from stakeholders to create a supportive environment that encourages the responsible and effective implementation of these technologies.

From portable diagnostic devices to mobile applications that facilitate real-time data transmission, the arsenal of point-of-care tools is expanding. These innovations empower healthcare providers to bring diagnostics closer to the point of patient interaction, minimising the need for extensive laboratory infrastructure.

Conclusion The journey towards enhanced point-of-care diagnostics is a journey towards a more accessible and responsive healthcare system. As technology continues to advance, the dream of providing quality diagnostics to all, irrespective of geographical or economic constraints, becomes increasingly attainable. By embracing these innovations and fostering collaboration, we can ensure that the transformative power of point-of-care diagnostics reaches every corner of the globe, ushering in a new era of healthcare accessibility and patient empowerment in the coming years.

EXPRESS HEALTHCARE

17

January 2024

DIAGNOSTICS

Technological advancements and genomics led actionability to play important role in improving healthcare landscape Dr Vedam Ramprasad, CEO, MedGenome stresses that the trajectory of genetic testing is evolving, with a focus on sequencing-based tests. This transition is noteworthy, with expectations of expanding applications to areas like cardiology and nephrology

T

he scope of the healthcare sector, in India has seen a paradigm shift over the last couple of years, driven by scientific advancements, application of scientific methods for treatment of diseases, increased awareness and affordability and improved accessibility of healthcare services.

Going forward evolving delivery models, availability of high-quality services, focus on patient safety and cost-effective diagnosis, management and treatment.

AI and ML driven technological advancements and genomics led actionability, will play an increasingly important role in improving the overall healthcare landscape.

Particularly, genomics in India has experienced significant growth over the past decade, with advancements in actionable insights. While genomics has been present in India for some time, its influence on disease diagnosis and management has gained traction only in recent years. This shift is attributed to increased awareness and understanding among clinicians and patients on the benefits of genomics in healthcare decisionmaking.

The concept of actionability

18 EXPRESS HEALTHCARE January 2024

in genomics has undergone a paradigm shift. Today, we are witnessing a completely different scenario. Today, drugs are formulated based on genetic mutations, preventive strategies are rooted in genetic insights, and treatments are tailored to specific mutations. The field of prognosis has also expanded, allowing anticipation of disease trajectories. The scope of genomics has expanded beyond its initial boundaries, covering a wide range of diseases. In various diseases, including non-com-

municable ones, the extent of genetic involvement can vary significantly. The interplay between genetics, lifestyle, and environmental factors influences various diseases, leading to a deeper understanding of genetic underpinnings. While conditions like pure Down syndrome are wholly genetic, others showcase a blend of genetic and external elements.

This ongoing biological exploration and the emergence of novel scientific advancements over the past decade have been truly remarkable. The Online

Mendelian Inheritance in Man (OMIM) database, a cornerstone of genetic information, records 100-150 new diseases and genes annually, refining approaches in diagnosis and management.

This transformative shift extends beyond genetics, impacting the entire medical landscape.

Leukaemia diagnosis, for example, has evolved from visual analysis to genetics-based classification, requiring medical professionals to acquire new skills.

The next decade promises even more profound changes, and stakeholders must prepare for this shift.

The trajectory of genetic testing is evolving, with a focus on sequencing-based tests. This transition is noteworthy, with expectations of expanding applications to areas like cardiology and nephrology. In terms of access to new innovations in India, two upcoming tests - Liquid Biopsy and SPITSEQ are poised to reshape the genetic testing landscape in India. Liquid Biopsy, a non-invasive technique, offers advantages in critical cases, serving as an alternative or adjunct to tumor biopsy. The SPITSEQ test has the potential to revolutionize TB diagnosis by identifying drug-resistant TB

within 14 days, facilitating prompt and accurate treatment.

It is a critical step towards achieving Government of India’s goal of ending TB by 2030.

For realising potential in diverse sectors, we need a well establish data framework that can address key components like partnerships, data storage, usage protocols, consumer protection, and informed consent.

Collaboration between academia and industry is essential for transformative advancements in global patient welfare.

The contemporary landscape, vastly different from 15 years ago, emphasises the promise of an ideal partnership between academia and private industry.

This collaboration can leverage skill sets, human resources, and capital reserves to drive significant advancements.

Reflecting on 17-18 years within this sphere, the need for collaborative efforts, government support, and industry-academia partnerships is evident.

Meeting expectations will benefit all enterprises in the healthcare sector, fostering innovation, improving patient outcomes, and contributing to the global advancement of healthcare.

START-UP

Promising future of Indian health startups in the gut microbiota domain Dr Debojyoti Dhar, Co-founder & Director, Leucine Rich Bio emphasises that Indian health startups specialising in gut microbiota are poised for a successful future, driven by the country's ageing population, the surge in chronic illnesses, and the diverse gut microbiota profiles present within the nation

W

e have heard time and again that data is the new oil. Frequently used in reference to the digital economy, the statement holds true when it comes to the Indian gut microbiota. The term gut microbiota is used for the collection of the microorganisms that are present in our digestive tract. India is a megadiverse country and our diversity extends way beyond our culture, language, and traditions. Yes, Indian gut microbiota is the most diverse in the world and this gives Indian health startups a competitive edge over others as they have a repertoire of rich data that can be utilised for innovative medical interventions.

try needs novel thoughts and cutting-edge technologies if we have to beat the disease burden especially for a diverse and hugely populated country like India.

Diversity in gut microbiota profiles

The ageing population and the rise of chronic illness One of the primary drivers propelling the success of Indian health startups specialising in gut microbiota is the country's rapidly ageing population. According to India Ageing Report 2023, the country’s elderly population (aged 60 and above) will increase to 347 million by 2050 as compared to 149 million in 2022. This massive upsurge in the proportion of the elderly points towards the increased prevalence of age-related health issues. Chronic illnesses like diabetes, cardiovascular diseases, and gastrointestinal disorders are on the rise, creating a pressing need for innovative healthcare solutions.

Gut microbiota is central to maintaining overall health, influencing various bodily functions, including digestion, metabolism, and immune response. Understanding and manipulating the gut microbiome have become integral to

Gut microbiota is central to maintaining overall health, influencing various bodily functions, including digestion, metabolism, and immune response addressing the complexities of chronic illnesses, making health startups focusing on gut health a key player in India's evolving healthcare landscape.

Worldwide, startups active in this domain focus mainly on two aspects namely gut microbiota profiling using DIY kits and development of microbiota based novel solutions. The recent FDA approval of two microbiota “drugs” (Rebyota,

Ferring Pharma and Vowst, Seres Therapeutics) to treat C.difficile infection is shot in the arm for the microbiome domain.

Indian startups focusing on the gut microbiota too can bring in new paradigm shift in the healthcare system by providing preventive as well as therapeutics solutions to the current unmet need of the population. The life science indus-

The intricate interplay between genetics, lifestyle, and diet contributes to a wide array of microbiota compositions across different regions and communities in India. This diversity presents a unique opportunity for Indian health startups to tailor their solutions to specific population segments, offering personalised approaches to gut health. Did you know that the gut bacterial composition varies between Indian and Western populations? A study demonstrated that the Indian gut has the highest abundance of a bacterial genus called Prevotella due to consumption of a carbohydrate- and fibre-rich diet. The interesting part here is that such research gives a boost to the development of prebiotics and probiotics that are the lynchpin of gut health and in turn overall health.

Latest trends in gut microbiota startups The Indian health startup ecosystem is witnessing a surge in companies leveraging cutting-edge technologies to analyse and modulate gut microbiota. The country’s human microbiome market stood at USD 139.1 million and is expected to cross the USD 282 million mark by 2031. Advances in metagenomics, artificial intelligence, and data analytics are being harnessed to unravel the complexities of the gut microbiome, allowing for more accurate diagnostics and person-

alised interventions.

Indian microbiome testing kits enable people to get a snapshot of their gut health and receive personalised dietary recommendations to balance it in case an imbalance is observed in the test results. These DIY kits empower people to take proactive steps in maintaining a healthy gut, aligning with the growing trend of preventive healthcare while at the same time helping people manage existing health conditions like diabetes, inflammatory bowel syndrome, or obesity.

Public awareness: Paving the way forward The adoption rates of gut microbiota-focused health solutions are steadily increasing across urban areas. As awareness about the significance of gut health spreads, people are becoming more receptive to proactive measures for maintaining a balanced microbiome.

Health startups are utilising digital platforms, social media, and partnerships with healthcare providers to disseminate information and engage with a broader audience.

Summing up Indian health startups specialising in gut microbiota are poised for a successful future, driven by the country's ageing population, the surge in chronic illnesses, and the diverse gut microbiota profiles present within the nation. The latest trends in technology adoption and rising public awareness are further propelling the growth of these players. By constantly innovating and addressing the unique healthcare challenges in India, these startups are likely to raise the bar for success.

EXPRESS HEALTHCARE

19

January 2024

HEALTHCARE IT

Solving India's healthcare accessibility puzzle with AI in 2024 Chaitanya Raju, Executive Director, HealthPlix Technologies throws light on how AI is set to be a transformative force in 2024

I

ndia confronts a complex healthcare challenge, particularly in rural areas where almost 65 per cent of the population resides. With only 64 doctors available per 100,000 people, much below the global average of 150, digitisation and Artificial Intelligence (AI) will play a crucial role in addressing the healthcare accessibility challenge.

AI, set to be a transformative force in 2024, is already a US$ 20 Billion market in healthcare. AI will assist doctors by providing key data points and health risk profiles of patients, thereby helping with early detection of chronic disease risks, avoiding adverse drug reactions, preventive care, etc. For instance, AI analyses billions of data points related to the medical history of people who were diagnosed with Chronic Kidney Disease (CKD) and can predict the kind of patient profiles who can be at risk for CKD. Nudging the doctors about these predictions at the right time helps doctors make informed decisions about early detection and prevention plans for the patients they are treating.

Other than being an ally to the doctors, AI will actively be used in various healthcare applications such as diagnostics precision, medical imaging, surgical robotics, telemedicine, remote monitoring of patients’ vitals especially for patients with chronic health conditions, and Electronic Medical Records (EMRs). Recently during the COVID-19 pandemic, AI played a crucial role in ensuring that healthcare organisations can set up remote monitoring of patients at a record speed thus ensuring that even patients who could not access specialised hospitals could receive the best possible treatment through AIenabled remote monitoring

20 EXPRESS HEALTHCARE January 2024

Other than being an ally to the doctors,AI will actively be used in various healthcare applications such as diagnostics precision, medical imaging, surgical robotics, telemedicine, remote monitoring of patients’vitals especially for patients with chronic health conditions, and Electronic Medical Records (EMRs) technologies AI serves as a powerful tool in automating routine tasks, freeing up valuable time for doctors and helping them focus on more complex and nuanced aspects of patient care. For example, a good AI-enabled EMR can play a huge role in the endto-end automation of all medical compliance processes, insurance claims for the patients,

medical transcription, etc., and ensure that the doctors are not burdened with overseeing these tasks.

Beyond the clinics and hospitals, AI also plays a huge role in the healthcare ecosystem with its advanced capabilities in forecasting disease outbreaks, drug discovery, and development, expediting clinical studies, identifying genetic markers

associated with specific diseases Despite the undeniable benefits, the integration of AI in healthcare poses challenges and necessitates careful consideration of ethical implications.

Issues related to data privacy, security, and the potential for bias in algorithms must be addressed to ensure the responsible and equitable deployment of

AI technologies. As the healthcare industry embraces AI, a robust regulatory framework is essential to safeguard patient interests and maintain the highest standards of ethical conduct.

To unlock AI's full potential in healthcare, the focus has to be on building products and services that simplify the lives of critical stakeholders - doctors. Healthcare AI products should ensure that their products should seamlessly integrate with existing healthcare systems, EMRs, and other healthcare technologies. Interoperability is crucial for ensuring that AI tools can complement and enhance the overall healthcare ecosystem. The objective of AI should not merely be a technological overlay. AI should be a strategic partner that aims to elevate the standard of care and accessibility In conclusion, the role of AI in healthcare is multifaceted and transformative. As AI continues to evolve, it is essential to strike a balance between the capabilities of machines and the vast knowledge of doctors, ensuring that the healthcare ecosystem remains centered on the well-being of individuals stands not as a replacement for human expertise but as a formidable ally, amplifying the capabilities of doctors and reshaping the future of medicine towards a future where quality healthcare is accessible to all, regardless of geographic or economic barriers. The journey towards a healthier future involves leveraging the strengths of both doctors and AI, forging a path towards more personalised, efficient, and inclusive healthcare systems. Looking ahead, the future of AI in healthcare holds immense promise, especially in bridging the healthcare accessibility gap in India.

Navigating the healthtech landscape: From wearables to virtual care Hari Subramaniam, Founder & Director, LifeSigns delve into the latest trends within the industry, that are shaping the future of healthcare

H

ealthtech brims with wearables tracking every step, yet stumbles when it comes to bridging the gap between data and meaningful action. We need solutions that translate biometrics into personalised care, not just colorful graphs on a screen.

Where a lower density of skilled healthcare professionals (27.5 per 10,000 population), a stark divide between urban and rural areas, and a high reliance on out-of-pocket spending (62.4 per cent) make technological intervention essential. This is where healthtech startups rise to the challenge, offering innovative solutions to bridge these gaps and improve healthcare access and delivery.

Against this backdrop, the healthcare technology sector is undergoing a revolution. From the explosion of wearable devices that track our health in real-time to the rise of virtual care platforms that connect patients with doctors remotely, healthtech is transforming how we approach patient care. But amidst this excitement, challenges remain.

Virtual care revolution: Transforming healthcare delivery The virtual care revolution represents a paradigm shift in healthcare delivery. Telemedicine, remote patient monitoring, and virtual consultations are gaining widespread acceptance, offering patients convenient access to healthcare services from the comfort of their homes.

About 70 per cent of healthcare firms are investing in consumerfacing tech like apps, remote monitoring and virtual care.

Wearable technologies: A personalised approach to health Wearable devices have seam-

The healthcare technology sector is undergoing a revolution. From the explosion of wearable devices that track our health in real-time to the rise of virtual care platforms that connect patients with doctors remotely, healthtech is transforming how we approach patient care lessly become a part of our daily lives, going beyond being just accessories to becoming personal health companions. The popularity of fitness trackers, smartwatches, and health-focused wearables is skyrocketing, providing users with realtime insights into various aspects of their well-being.

These devices monitor physical activity, track heart rate, analyse sleep patterns, and more, empowering individuals to take an active role in managing their health. Recent data suggests that wearable technology has the potential to reduce

hospital costs by 16 per cent over a five-year period.

The adoption of wearables encourages preventive healthcare, motivating users to make informed lifestyle choices based on their health data. From promoting physical activity to alerting users about potential health issues, wearables contribute to a holistic approach to well-being.

Medical software: Enhancing healthcare processes At the heart of the healthtech revolution is medical software.

This sophisticated software integrates advanced algorithms and artificial intelligence to streamline healthcare processes, improve diagnostic accuracy, and elevate overall patient care. Medical Software enables the efficient management of medical data, allowing healthcare professionals to make informed decisions based on comprehensive and real-time information.

Deploying medical software in healthcare settings significantly reduces administrative burdens, enabling healthcare providers to focus more on patient care. The integration of machine learning algorithms enhances diagnostic capabilities, leading to more accurate and timely diagnoses. This not only improves patient outcomes but also contributes to the optimisation of healthcare resources.

Medtech innovations: Redefining possibilities in healthcare Medical technology (Medtech) innovations are pushing the boundaries of what is achievable in healthcare. From robotic-assisted surgeries to advanced imaging techniques, Medtech is driving substantial advancements in the field.

These innovations play a pivotal role in improving diagnostic precision, optimising treatment approaches, and ultimately enhancing patient outcomes.

The advent of medtech has led to the development of minimally invasive procedures, reducing patient recovery times and hospital stays. Robotics, artificial intelligence, and data analytics are seamlessly integrated into various medical devices, contributing to a more personalised and effective healthcare experience.

Challenges in adoption: Bridging the gap Despite the promising potential of these technologies, healthcare providers face challenges in their widespread adoption.

Integration into existing healthcare systems, concerns about data security and privacy, and the need for standardised regulations pose significant hurdles.

Successfully implementing healthtech solutions requires collaborative efforts between technology developers, healthcare professionals, and regulatory bodies.

Establishing interoperability standards and frameworks is crucial to ensuring the seamless integration of new technologies into existing healthcare infrastructures. Addressing concerns related to data security and privacy is paramount to building trust among both healthcare providers and patients. Additionally, fostering a culture of innovation and providing education and training to healthcare professionals are essential components of overcoming adoption challenges.

Conclusion: Towards a connected healthcare future As we navigate the evolving healthtech landscape, the integration of wearables, Intelligent Medical Software, and medtech innovations is transforming the healthcare industry. Virtual care solutions, exemplified by many health tech platforms are bridging gaps in accessibility and revolutionising patient care dynamics. Challenges persist, but the promise of a more connected, data-driven, and patient-centric healthcare future is within reach. Embracing innovation collaboratively is paramount to realising the transformative potential of these technologies and ensuring improved global health outcomes.

EXPRESS HEALTHCARE

21

January 2024

HEALTHCARE IT

Emerging business models in healthcare Raghunandan Hanumanthu, Vice President and Industry Platform Leader for Life Sciences – India, Capgemini talks about the trends that will enhance the sector in 2024 Emerging business models in medtech The medtech industry is witnessing the development of new SaMD (Software as Medical Device) products and DTX (Digital Therapeutics).

SaMD can include various software used for electrocardiogram (ECG) analysis, insulin pumps, health apps, among others. DTX is evidence-based and clinicallyevaluated software to treat, manage, and prevent a broad spectrum of diseases and disorders. DTX can be used as a

monotherapy or can be complemented with traditional treatments. Growing investment in software-based treatments is transforming patient experience and the delivery landscape.

Medical robotics and immersive healthcare experience Patient care and healthcare outcomes can be significantly enhanced using a combination of robotics and immersive technologies such as Augmented Reality (AR), Vir-

tual Reality (VR), and Mixed Reality (MR). Digital surgeries are using immersive technologies to help improve accuracy, precision cuts, and visualisation. Other key applications of immersive technologies include medical training and patient management during stressful situations, anxiety, and other personal phobias.

High investment in these technologies indicates a growing demand for immersive health experiences and improved health outcomes.

AI-driven innovation The introduction of a new drug in the market requires up to $1.5-2 billion for research and development (R&D), followed by commercialisation. On an average, it takes about 10-15 years to successfully launch a product. The use of Artificial Intelligence (AI) in pharma is helping companies accelerate drug discovery, improve clinical trial efficiencies, automate and optimise Continued on Page 23

Emaa i l: rajesh.bb h ajnik@expp r essindia.. com ■ C ontt act Noo .9867144 5022 8 Company N am m e-- Thh e Indian Express (PP ) Ltd, Company Address-Mafatlal C enn trr e,, 7tt h Floor,Ramnath Goenka Marg, Nariman P oii ntt , Mumbai-400021.· Bank Naa mee -H H DFF C Bank Ltd d ress-C-- 5/32, Safdd arjung Devv elopment Area ( SDA), New Delhi-110016.. ● Baa nk Add 0 75 ● Swift Code-HDFF CINBB ● IFSC -HD D FC0000032·· A ccount Type-- Current ● Accoo unt -003286300000

22 EXPRESS HEALTHCARE January 2024

HEALTHCARE IT

HowAR and VR are revolutionising telehealth Ranga Jagannath, Senior Director-Growth, Agora explains how AR and VR holds the promise of introducing a transformative era in healthcare delivery

T

echnological progress has consistently facilitated healthcare practitioners in providing improved healthcare. Beyond the innovations in Artificial Intelligence (AI) for telehealth, progress in Augmented Reality (AR) and Virtual Reality (VR) holds the promise of introducing a transformative era in healthcare delivery.

AR and VR technology enable doctors to overcome physical location limits and provide remote patient care while also improving in-person care in some aspects. Healthcare systems are beginning to recognise the significant impact that combining AR/VR and telehealth will have on a wide range of healthcare services. A recent study from Deloitte indicates that 80 per cent of healthcare professionals believe the significant impact that AR/VR are going to have on healthcare in the next five years.

AR and VR in telehealth AR combines the actual surroundings of the user with virtual visuals and digital data, resulting in a live, interactive encounter that supplements the natural environment with digital perceptual information. In the realm of telehealth, AR enables healthcare professionals to incorporate visual and data-driven overlays using devices like smartphones. This capability aids doctors in virtual diagnosis and provides valuable information to patients.

VR on the other hand is an all-encompassing, entirely simu-

lated environment that substitutes or duplicates the realworld setting. Utilising headsets or integrated multi-projected simulations, VR generates the sights, sounds, and sensations of an actual environment within a virtual realm. In telehealth, VR can facilitate diverse scenarios, ranging from completely immersive 360-degree virtual appointments to enabling physicians to conduct virtual surgeries while managing a surgical device through VR interfaces.

AR and VR technology to improve telehealth experiences In today's digital-centric era, over 3 billion people possess

high-definition cameras and enjoy enhanced connectivity. Telehealth technologies, such as inapp video calling, enable doctors to engage with their patients through HD video and voice calls.

AR and VR enhance the conventional telehealth video call by offering significant visual advantages for both providers and patients. When combined with computer vision utilizing AI for visual analysis and identification, these technologies have the potential to elevate virtual healthcare communication to a new level, delivering benefits that extend beyond the scope of typical in-person appointments.

The incorporation of AR and

VR holds the promise of addressing various telehealth challenges faced by doctors, including precise diagnosis, the execution of virtual and minimally invasive surgeries, and effective patient management.

Use cases of AR/VR that are expected to revolutionise the future of healthcare delivery and patient experience: ◆ Cross-functional collaboration: Specialists, surgeons, and clinicians from diverse locations can employ AR/VR to collaboratively engage in real-time discussions, examining a patient's medical records, diagnosing conditions, and deliberating on subsequent treatment strategies. ◆ Remote patient surgery and care: The utilisation of AR and VR technology allows surgeons to conduct intricate medical procedures from a distance, thereby enhancing healthcare accessibility for those in need. Furthermore, immediate access to patient data and seamless connectivity with other specialists empower healthcare providers to achieve improved outcomes. ◆ Healthcare professional training: Technology-driven reality enables medical and allied medical personnel to participate in training sessions within a secure, regulated, and immersive learning setting. These sessions offer precise feedback by recognising specific areas for professional improvement and delivering tailored training exercises. ◆ Patient education: Patients who are well-informed also play a

role in improving treatment outcomes. AR and VR technology offer a means for doctors to educate patients about their present health status, available treatment alternatives, and the potential impacts of procedures like surgery through realistic depictions of their heart or brain.

AR, especially, is easily accessible to patients, requiring only a smartphone camera. Through an AR telehealth application, a patient could use their camera to receive overlays of information and visuals, offering educational insights into aspects like recovery from an injury by pointing it at their leg. ◆ Remote post-surgery patient care: AR and VR technologies aid physicians in real-time comprehension of a patient's condition during remote care.

VR can additionally assist patients in effectively coping with discomfort or pain by immersing them in calming virtual environments or providing specific rehabilitation instructions and exercises through AR. ◆ Mental healthcare: AR and VR find applications in mental health treatment. For instance, VR can deliver tranquil and soothing experiences, aiding individuals in stress and anxiety management or easing the distress and fear associated with a patient who has undergone a traumatic event. When integrated into virtual therapy sessions, these immersive experiences hold significant potential for addressing a diverse range of mental health conditions.

companies build a positive brand image and deliver more value. Pharma companies are investing significantly in digital technologies to provide personalised and on-demand services to

HCPs, sales representatives, and patients. Cloud-based applications are yielding cost benefits and encouraging companies to relook at their sales and marketing IT portfolios.

Emerging business...

Continued from Page 22 manufacturing processes, design effective marketing and post-launch strategies, and develop personalised medicines. Over the next few

years, the application of AI tools for healthcare professional (HCP) engagement and commercialisation can significantly transform the go-tomarket strategies of pharma companies.

Future of Customer Experience (CX) CX is driven by several interactions among sales representatives, HCPs, and patients. An efficient CX strategy can help pharma

EXPRESS HEALTHCARE

23

January 2024

RADIOLOGY & IMAGING

Advancements in radiology and imaging: Transforming healthcare delivery Dr Gautam Wankhede, Director of Medical Affairs, Mylab Discovery Solutions stresses that the integration of AI into radiology and teleradiology heralds a new era in healthcare delivery, characterised by improved diagnostics and expanded accessibility

R

adiological examinations play a crucial role in ensuring precise diagnoses, risk assessment, and prognosis for various medical conditions. The inception of medical imaging dates back to the discovery of X-rays by Wilhelm Roentgen in 1895. This groundbreaking revelation paved the way for non-invasive visualisation of the internal structures of the human body.

Subsequent decades witnessed the development of modalities such as computed tomography (CT), magnetic resonance imaging (MRI), ultrasound, and positron emission tomography (PET), each contributing to a deeper understanding of anatomical and functional aspects. The future promises not only enhanced precision in medical diagnoses but also greater accessibility and personalised patient care through cuttingedge imaging technologies.

A significant portion of our population resides in rural areas, facing challenges in accessing healthcare, top-tier diagnostics, and specialised consultations.

The distribution of radiology facilities across the country is uneven, with a concentration of trained radiologists primarily in larger cities and towns, resulting in a shortage of radiologists in the country.

To address these disparities between demand and supply, teleradiology has emerged as an effective solution. The implementation of Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS) has significantly enhanced the efficiency, productivity, and throughput of imaging services. Advancements in internet and mobile connectivity, the integration of teleradiology, Artificial Intelligence (AI), developments

24 EXPRESS HEALTHCARE January 2024

diagnosis and facilitates immediate medical interventions.

Accessibility in remote areas

The implementation of Picture Archiving and Communication Systems (PACS) and Radiology Information Systems (RIS) has significantly enhanced the efficiency, productivity, and throughput of imaging services in medical imaging informatics, and the introduction of portable or mobile medical imaging devices hold the potential to extend access to improved healthcare and diagnostics in remote locations throughout the country.

Portability and field usability The demand for portable imaging devices has risen, enabling healthcare professionals to extend diagnostic capabilities beyond traditional healthcare settings. Portable ultrasound

machines, handheld X-ray devices, and compact MRI systems have become indispensable tools for point-of-care diagnostics.

The ability to carry out imaging procedures at the patient's bedside, in ambulances, or remote locations enhances the speed of

Advancements in digital radiography, particularly Mobile Digital Radiography (DR) systems, bridge access gaps in rural areas. The integration of imaging technologies with telemedicine has greatly improved healthcare accessibility in remote and underserved areas. Portable imaging devices, when combined with telehealth platforms, allow for remote consultations and diagnostic image interpretation. This ensures that individuals in geographically isolated regions have access to timely and accurate medical imaging services, thereby bridging the gap in healthcare disparities.

The transition from filmbased to digital radiography represents a pivotal moment in the history of medical imaging. This technological leap not only enhances the efficiency of diagnostic processes but also raises the bar for diagnostic accuracy and patient care. As digital radiography continues to evolve, the focus is on further refining image resolution and optimising image processing algorithms. From routine screenings to intricate diagnostic procedures, the advantages of digital X-ray technology are pervasive. Orthopaedics, cardiology, pulmonology, and emergency medicine are among the fields that have witnessed notable improvements in diagnostic capabilities.

Another groundbreaking development in point-of-care imaging is the introduction of Mobile Digital Radiography (DR) systems. These mobile digital X-ray units play a crucial role in bridging access gaps in rural areas of India. The transition from conventional screen film

radiography to digital X-ray units is driven by improved accuracy, reduced radiation dose, enhanced workflow, and seamless integration with Picture Archiving and Communication Systems (PACS) and teleradiology. This transition signifies a significant stride toward more advanced and efficient diagnostic imaging in healthcare.

Ease of use and safety A notable trend in recent developments is the emphasis on ease of use and safety in imaging technologies. User-friendly interfaces, simplified workflows, and intuitive controls make these devices more accessible to a broader range of healthcare professionals. Additionally, advancements in safety features, such as reduced radiation exposure in X-ray and CT scans, contribute to patient well-being

while maintaining diagnostic accuracy.

AI integration The integration of AI into radiology and teleradiology heralds a new era in healthcare delivery, characterised by improved diagnostics and expanded accessibility. As AI continues to evolve, its synergy with teleradiology and mobile digital imaging units promises to overcome challenges, ensuring that individuals, regardless of geographic location, receive timely and accurate medical imaging services. This collaborative approach not only addresses the shortage of radiologists but also enhances the overall efficiency of healthcare systems, fostering a future where advanced technology plays a critical role in improving patient outcomes.

The enhanced value that teleradiology and cutting-edge

technologies, including AI, bring to emergency and trauma care is paramount. Their impact extends to improving access to imaging services and subspecialty care in remote geographical areas. Furthermore, they play a crucial role in supporting and enabling population-based screening programs for diseases like tuberculosis and cancer.

Presently, AI is extensively integrated into scanners to optimise image quality and reduce scan time.

AI’s role is particularly pronounced in emergency and trauma care. It excels in offering initial readings to distinguish normal from abnormal chest Xrays and identifying specific diseases such as pneumonia, pleural effusion, TB, intracranial bleed, fractures, and breast cancer with exceptional accuracy.

In primary care settings, where chest X-rays, obstetric ul-

trasound, plain CT brain, and mammography are commonly required, AI emerges as a versatile tool. Additionally, AI can function as a triage system, efficiently identifying imaging that necessitates an urgent second read by remotely located radiologists. a. Automated image analysis: AI algorithms can analyse vast datasets of medical images rapidly. This automation expedites the identification of subtle abnormalities, contributing to quicker and more accurate diagnoses. b. Predictive analytics AI leverages predictive analytics by analysing historical patient data and imaging results.

This enables the identification of trends, prediction of potential health risks, and customisation of preventive measures or treatment plans for individuals. c. Workflow optimisation

Integrating AI into radiology workflows streamlines image analysis, prioritises urgent cases, and enhances overall operational efficiency. Radiologists can focus on complex cases, while routine interpretations are expedited through AI assistance.

Conclusion The latest developments and trends in radiology and imaging represent a transformative era in healthcare. The focus on portability, field usability, accessibility in remote areas, ease of use, safety, and AI integration is transforming how diagnostic services are delivered. As these advancements continue to evolve, the future of radiology promises a healthcare landscape that is not only technologically advanced but also patient-centric, ensuring improved healthcare outcomes for individuals worldwide.

EXPRESS HEALTHCARE

25

January 2024

HOSPITAL INFRASTRUCTURE

Creating hospitality-oriented environment for patients Ashok Singh Jaunapuria, Managing Director and CEO, SS Group India highlights that as we enter new year, developers and designers in healthcare facilities are giving importance to advancements in technology, sustainability, and patient experience

T

he room looked like a plush hotel, with all the comforts of modern living, giving one a homely feel, with a dash of greenery thrown around, bringing in the natural hue. But imagine this very room to be a hospital room, where a patient is recuperating from some illness or is under post operation care.

Wouldn’t the idea of being in such a room be great, where the psyche and the mental power to overcome the trauma of an illness gets a wonderful boost thanks to the homely ambience of the surroundings? Jump to 2024 and most modern age hospitals are wishing to have trendsetting designs that would change the previous concept of a chloroform and ethanol stinking hospital bed where the surroundings made patients mentally sick and you take days to get fit again, you start considering yourself as a ‘true blue patient.’ But modern hospitals and physicians have a different take. Starting from maternity wards to cardiology and oncology wards, the set up and infrastructure are going through a sea change in designs, to help the patient get fit faster than one could ever imagine, keeping their mental state boosted. For most modern physicians believe half of everyone’s disease is in the head.

The healthcare facility designs are thus adapting to evolving patient and staff needs, with a focus on providing a more ‘hospitality-oriented environment’ for patients than ‘hospital oriented.’

As we enter new year, developers and designers in healthcare facilities are giving importance to advancements in technology, sustainability, and patient experience. Most

26 EXPRESS HEALTHCARE January 2024

With the ongoing growth in expertise and success rates, even outpatient settings are being changed incorporating technologies in robotics and imaging within surgical suites

healthcare facility designs including operation theatres, nursing stations, labour rooms, delivery rooms, cathlabs are now less invasive. In a broader range of procedures, robotic applications are becoming increasingly prevalent that are driving a need and creating demand for more flexibility within surgical spaces where imaging modalities are increasingly more integrated. With the ongoing growth in expertise and success rates, even outpatient settings are being changed incorporating technologies in robotics and imaging within surgical suites.

These days the infrastructure design keeps in mind the need of both patients and staff.

Patients and their families expect a more ‘hospitality feel’ and not the age old ‘hospital feel’ in facilities. Thus, a sea change is observed in the designs that are made. For staff, healthcare facilities are grappling with recruitment and retention pressures, which are driving the need for additional staff amenities such as 'offstage' areas for collaboration and relaxation. The sustainable hospital design models are also turning eco-friendly to reduce environmental impact, that is needed for boosting up health in an environment of a hospital that is anyway plagued with disease and death. Hence the natural factors are taken into account while building, to bring in a happiness quotient. Also, hospitals account for approximately 10 percent of all carbon emissions, so sustainability remains crucial for hospital owners. Some sustainable features one would like to look into in 2024 include carbon-dioxide monitoring and energy harvesting, such as converting

steam waste into a reusable resource. The furniture and furnishing in the hospitals also need to be eco-friendly when designing interior spaces, including stain-resistant chemicals and additional microbial treatments for surfaces in healthcare settings.

Energy-efficient LED lighting and high-performance building envelopes in walls and roofs will be some trends to look into hospital designs of 2024.

With a modern shift to remote and telehealth visits, hospital designs have undergone a few changes if not significant ones. Certain modalities like behavioral health and low acuity care do still lend themselves to telehealth visits which keep patients in a comfortable setting and may actually improve the output of provider services. Design must consider the infrastructure requirements needed to support the virtual visit in those cases. Additionally, there should be comfortable spaces for providers to host these interactions virtually.

Today, technology is being used to create efficient and effective hospitals that offer human-centric experiences.

From just being digital to being Smart, hospitals are working to optimise, redesign and build new clinical processes, management systems, digitised networking infrastructure to provide a valuable service to achieve better patient care, experience, and operational efficiency. Virtual hospital wards are an example of this trend in action in 2024 where a central location acts as a hub for monitoring multiple patients in their own homes! Thus 2024 would see a sea of change in hospital infrastructure for sure.

Elevating healthcare design: Vision for 2024 and beyond Ravideep Singh, Associate Director, Creative Designer Architects (CDA) shares that in 2024, healthcare will not be perceived as a service; it should be an experience crafted with empathy, innovation and inclusivity

I

n an era defined by rapid technological advancement and a growing emphasis on wellness, the healthcare design industry finds itself at the nexus of innovation and societal impact. As we set our sights on 2024, it's crucial to explore the evolving landscape of hospital infrastructure, not merely as a physical space but as a testament to the industry's commitment to holistic well-being.

only reduces costs but also mitigates the risk of life-threatening downtime, enhancing the overall efficiency and cost-effectiveness of construction.

Digital health and technology further contribute to climate-friendly hospital design.

Intelligent hospital buildings leverage smart sensors to optimise high energy usage, utilising natural elements like daylight, temperature, and air quality for a healing environment. Solar passive building design integrates these elements, adjusting lighting, heating, and cooling systems in real-time to environmental conditions. This comprehensive approach minimises reliance on mechanical systems, fostering sustainability and reducing the carbon footprint of healthcare facilities.

Harmonising technology and humanity In the trajectory toward the future, the orchestration of advanced technologies, such as Artificial Intelligence (AI) and predictive maintenance, becomes a pivotal element in the narrative of healthcare design.

This isn't merely a pursuit of energy efficiency; it's a strategic journey toward creating environments that prioritise the individual, where architectural insights are harnessed to craft spaces that transcend mere functionality. Beyond the confines of traditional healthcare thinking, these innovations aim to enhance patient experiences.

In the pursuit of sustainable healthcare architecture, the integration of digital health and technology emerges as a pivotal strategy. By seamlessly incorporating digital health solutions into architectural design, hospitals can enhance energy efficiency, minimize their carbon footprint, and create healing environments that elevate patient experiences.

AI and predictive maintenance revolutionise healthcare infrastructure. By harnessing data from diverse sensors integrated with a centralised Building Management System (BMS), AI-driven predictive maintenance optimises energy efficiency, extends the lifespan

Wellness design trends

Healthcare planners need to understand the role of shaping public spaces that transcend the clinical and embrace the community. Hospitals can become beacons of wellness, not just for patients but for the entire community of critical infrastructure, and empowers architects with in-

sights into patient preferences.

This proactive approach not

The wellness design trends reshaping hospital infrastructure. The concept of biophilic design, incorporating natural elements into the built environment, is gaining momentum.

Imagine hospitals adorned with greenery, natural light streaming in, and spaces designed to evoke a sense of tranquility – a far cry from sterile environments of the past. This isn't just an aesthetic choice; it's a paradigm shift towards designs that promote healing and well-being.

Social impact The societal impact of these trends is profound. Imagine a healthcare facility that not only treats ailments but also contributes to the overall well-being of the community. Green spaces within hospitals become shared areas for relaxation, promoting mental health. Patient-centric designs acknowledge the diverse needs and

preferences of individuals, fostering a sense of inclusivity. As thought leaders in healthcare design, we recognise the power of our creations to shape societal attitudes towards health, inclusivity, and the environment.

Digital healthcare for all Our vision extends beyond physical spaces to the realm of digital healthcare. The integration of AI, Augmented Reality (AR), and Virtual Reality (VR) is not just about cutting-edge technology; it's a commitment to revolutionise patient interactions. Natural Language Processing (NLP) and AI-powered chatbots go beyond functionality; they become companions, easing patient concerns and gathering invaluable insights into their needs. In 2024, healthcare will not be perceived as a service; it should be an experience crafted with empathy, innovation and inclusivity.

Healthcare planners need to understand the role of shaping public spaces that transcend the clinical and embrace the community. Hospitals can become beacons of wellness, not just for patients but for the entire community. The shift towards eco-friendly designs and sustainable practices is a commitment to environmental stewardship, impacting communities for generations.

With the increasing awareness of holistic wellness, the vision for 2024 is not merely a projection of design trends; it's a call to action for a more compassionate, inclusive, and sustainable future. The hospitals we design are not just structures; they are statements – statements of a future where healthcare is not just a necessity but a celebration of life, wellness, and the human spirit.

EXPRESS HEALTHCARE

27

January 2024

INSURANCE

Healthcare financing: Prescription for India's healthcare delivery revolution Shyatto Raha founder and CEO, Myhealthcare stresses that healthcare financing emerges as the prescription for a revolutionary transformation in India's healthcare finance terrain, offering unparalleled benefits to individual customers and hospitals alike Predictions for 2024: Charting the course ahead

I

n the realm of healthcare, India finds itself at a crossroads, catching up with both challenges and opportunities that shape the nation's well-being. Despite being a major global player, India lags behind in overall healthcare spending as a percentage of GDP, underscoring the critical need for strategic interventions.

How the year unfolded: A reflective analysis ◆ Increased investor interest: Reflecting on the past year, the insurtech sector witnessed a surge in investor interest, particularly in the health domain. Platforms addressing the unique challenges of the Indian healthcare landscape garnered attention, with investors recognising not only the financial viability but also the societal impact of these innovative solutions.

Encouragingly, the expanding insurance coverage landscape is making healthcare more accessible to a larger population. The funding environment remains robust, with over $1 billion flowing into health tech in 2022, indicating sustained investor confidence. ◆ Emphasise on tailored health plans: Another noteworthy change is the individualisation of health plans. The evolution towards more personalised and inclusive health plans is a notable trend. Insurtech platforms are moving beyond corporate plans, with a growing number of individuals recognising the value of tailored health solutions. This shift reflects a broader goal of inclusivity, with insurtech platforms aiming to cater to the diverse needs of the masses. ◆ Healthcare spending and medical inflation: India, compared to major economies, fell

28 EXPRESS HEALTHCARE January 2024

The landscape of financial services is undergoing a transformative shift with the introduction of innovative and paperless financing options in collaboration with leading Non-Banking Financial Companies (NBFCs) in India short in dedicating a significant proportion of its GDP to healthcare. Interestingly, even as COVID-related hospitalisations decrease, the country experiences the highest healthcare inflation, spotlighting the need for effective cost management strategies. ◆ Digital health: Catalyst for change: The rapid penetration of technology, coupled with a growing consumer preference for online healthcare services, is going to be a transformative

force. Digital healthcare adoption, which gained momentum during the pandemic, has become a permanent fixture, reshaping consumer behavior. ◆ Government initiatives: The government's proactive measures, such as the Ayushman Bharat Digital Mission (ABDM), acted as a significant push towards an integrated digital health infrastructure. This not only facilitates improved access but also aligns with the rising

focus on preventive care and health management postCOVID-19. ◆ Increased awareness and demand for healthcare financing: A notable transformation is unfolding in healthcare financing. The Ayushman Bharat scheme has enhanced accessibility, digital distribution channels have widened penetration, and heightened awareness has underscored the importance of healthcare insurance.

◆ Preventive healthcare takes center stage Anticipating the future, there's a clear trajectory towards preventive healthcare.

Insurtech platforms are expected to play a pivotal role in promoting wellness and proactive healthcare measures. The emphasis on OPD coverage is likely to become mainstream, addressing a significant gap in the current health insurance landscape. ◆ Technology as a catalyst for change The role of technology is set to expand further, with insurtech platforms leveraging data for better risk assessment and tailoring solutions to individual needs. The integration of technology is poised to enhance operational efficiency and bring about a paradigm shift in how healthcare is accessed and financed. ◆ Future outlook The trajectory of India's health insurance sector in 2024 reflects a commitment to inclusive and accessible healthcare. As insurtech platforms continue to innovate, collaborate, and address longstanding challenges, they play a pivotal role in shaping the future of healthcare financing in the country. The infusion of funds, technological advancements, and a focus on preventive healthcare signal a promising path ahead, with insurtech platforms emerging as key contributors to India's evolving healthcare narrative.

As the nation strives for better health outcomes, the interplay of technology, awareness, and strategic initiatives will determine how India's healthcare sector evolves in the years to come.

Anticipating 2024’s India’s insurtech landscape Aniruddha Sen, Co-founder, Kenko Health highlights that the trajectory of India's health insurance sector in 2024 reflects a commitment to inclusive and accessible healthcare

I

n the realm of healthcare, India finds itself at a crossroads, catching up with both challenges and opportunities that shape the nation's well-being. Despite being a major global player, India lags behind in overall healthcare spending as a percentage of GDP, underscoring the critical need for strategic interventions.

penetration, and heightened awareness has underscored the importance of healthcare insurance.

Predictions for 2024: Charting the course ahead

How the year unfolded: A reflective analysis ◆ Increased investor interest: Reflecting on the past year, the insurtech sector witnessed a surge in investor interest, particularly in the health domain. Platforms addressing the unique challenges of the Indian healthcare landscape garnered attention, with investors recognising not only the financial viability but also the societal impact of these innovative solutions.

Encouragingly, the expanding insurance coverage landscape is making healthcare more accessible to a larger population. The funding environment remains robust, with over $1 billion flowing into health tech in 2022, indicating sustained investor confidence. ◆ Emphasise on tailored health plans: Another noteworthy change is the individualisation of health plans. The evolution towards more personalised and inclusive health plans is a notable trend. Insurtech platforms are moving beyond corporate plans, with a growing number of individuals recognising the value of tailored health solutions. This shift reflects a broader goal of inclusivity, with insurtech platforms aiming to cater to the diverse needs of the masses. ◆ Healthcare spending and medical inflation: India, compared to major economies, fell short in dedicating a significant proportion of its GDP to healthcare. Interestingly, even as COVID-related hospitalisations

Anticipating the future, there's a clear trajectory towards preventive healthcare. Insurtech platforms are expected to play a pivotal role in promoting wellness and proactive healthcare measures decrease, the country experiences the highest healthcare inflation, spotlighting the need for effective cost management strategies. ◆ Digital health: Catalyst for change: The rapid penetration of technology, coupled with a growing consumer preference for online healthcare services, is going to be a transformative force. Digital healthcare adop-

tion, which gained momentum during the pandemic, has become a permanent fixture, reshaping consumer behavior. ◆ Government initiatives: The government's proactive measures, such as the Ayushman Bharat Digital Mission (ABDM), acted as a significant push towards an integrated digital health infrastructure.

This not only facilitates im-

proved access but also aligns with the rising focus on preventive care and health management post-COVID-19. ◆ Increased awareness and demand for healthcare financing: A notable transformation is unfolding in healthcare financing. The Ayushman Bharat scheme has enhanced accessibility, digital distribution channels have widened

◆ Preventive healthcare takes center stage Anticipating the future, there's a clear trajectory towards preventive healthcare.

Insurtech platforms are expected to play a pivotal role in promoting wellness and proactive healthcare measures. The emphasis on OPD coverage is likely to become mainstream, addressing a significant gap in the current health insurance landscape. ◆ Technology as a catalyst for change The role of technology is set to expand further, with insurtech platforms leveraging data for better risk assessment and tailoring solutions to individual needs. The integration of technology is poised to enhance operational efficiency and bring about a paradigm shift in how healthcare is accessed and financed. ◆ Future outlook The trajectory of India's health insurance sector in 2024 reflects a commitment to inclusive and accessible healthcare.

As insurtech platforms continue to innovate, collaborate, and address longstanding challenges, they play a pivotal role in shaping the future of healthcare financing in the country.

The infusion of funds, technological advancements, and a focus on preventive healthcare signal a promising path ahead, with insurtech platforms emerging as key contributors to India's evolving healthcare narrative.

As the nation strives for better health outcomes, the interplay of technology, awareness, and strategic initiatives will determine how India's healthcare sector evolves in the years to come.

EXPRESS HEALTHCARE

29

January 2024

BUSINESS AVENUES

30

January 2024

EXPRESS HEALTHCARE

EXPRESS HEALTHCARE

BUSINESS AVENUES

EXPRESS HEALTHCARE

EXPRESS HEALTHCARE

January 2024

31

BUSINESS AVENUES

EXPRESS HEALTHCARE

M. K. Silicone Products Pvt. Ltd. S I L I C O N E T R A N S P A R E N T T U B I N G

for the Quality Conscious….

To Advertise in

Business Avenues CE

Quality Products 1997

L

C

An ISO 9001-2015 COMPANY

IS0 8

Since

EA

NRO

O

208, Hill View Industrial Premises, Amrut Nagar, Ghatkopar (W), Mumbai - 400 086, India.

Mob.: 9321965968 / 9869412342 E-mail : sales@mksilicone.com

32

January 2024

Email: rajesh.bhatkal@expressindia.com Blue Heaven

QM 002

M

INDIA

RTIFIED

rbhatkal@gmail.com

EXPRESS HEALTHCARE

BUSINESS AVENUES

EXPRESS HEALTHCARE

Cover the Length and Breadth of India 58,000 sqmt of exhibition space

India's Largest & No.1 Healthcare Event & Hospital needs Exhibition

36th Edition | FEB 2024

16 17 18 MUMBAI NESCO

37th Edition | APR 2024

6

7

8

HYDERABAD

HITEX EXHIBITION CENTER

38th Edition | AUG 2024

2

3

4

CHENNAI

CHENNAI TRADE CENTER

39th Edition | OCT 2024

5

6

7

NEW DELHI PRAGATI MAIDAN

For enquiries: +91 7305 789 789 | www.medicall.in | info@medicall.in

EXPRESS HEALTHCARE

January 2024

33

BUSINESS AVENUES

EXPRESS HEALTHCARE

29th International Exhibition and Conference

BOMBAY EXHIBITION CENTER MUMBAI, INDIA

13–15 MARCH 2024 INDIA’S NO. 1 TRADE FAIR FOR HOSPITALS, HEALTH CENTRES AND CLINICS SHOW HIGHLIGHTS

16,000 m2

500+

25+

EXHIBIT AREA

EXHIBITORS

EXHIBITING COUNTRIES

15,000+

60+

4

VISITORS

VISITING COUNTRIES

CONFERENCES

500+ DELEGATES

SPECIAL FEATURES

in-vitro Diagnostics Pavilion

Make in India Pavilion

IVD Pavilion & Conference

Rehabilitation Pavilion

Digital Health Pavilion

International Conferences

MT India Healthcare Awards

For more information, please contact: Adarsh Verma - Tel.: +91 (0)124 4544 507, E-mail: VermaA@md-india.com Powered by

34

January 2024

Supported by

Media Partner

EXPRESS HEALTHCARE

HEALTHCARE TRACKER I N T E R V I E W

Securing India's position as global medtech hub Chaitanya Sarawate, Managing Director, Wipro GE Healthcare in an interaction with Express Healthcare talks about the growth of medtech sector How do you anticipate the growth of the medtech sector, considering the objectives outlined in the National Medical Devices Policy 2023?

The healthcare market in India is dynamic with a broad spectrum of opportunities.

With introduction of the National Medical Policy (NMDP) 2023, India is on the brink of a significant transformation in the medtech industry. The policy takes a holistic approach by focusing on innovation, manufacturing, and quality.

With an aim to capture a 10-12 per cent share of the growing global market over the next 25 years, the policy provides a well-defined roadmap to make the sector more innovative, competitive, and self-reliant, not just for India but also to meet global needs. We can expect to see enhanced patient outcomes, job creation, strengthened foreign exchange earnings and an accelerated growth of the medtech sector.

Medtech, however, is a complex sector and to realise this vision for India, some aspects will require further deliberation-harmonisation with global quality standards, investments in R&D to foster indigenous innovation, and a comprehensive approach to local manufacturing with locally procured components, for sustainable growth.

Even though Public Procurement Policy prioritises ‘Make in India’ products, we are still heavily import dependent. How can we change that?

The reduction on import dependency rests on multiple factors – prioritising procurement of domestically manufactured products, offering support to states to strengthen their markets, and

Achieving the goal of reducing import dependency from 80 per cent to 50 per cent by 2030, in alignment with the Make in India and Make for India initiatives, all while maintaining stringent quality standards, demands a holistic strategy simplifying regulatory framework to enhance accessibility for a wider population.

For instance, government allows import of selected products/technologies that

are not locally manufactured.

This list is reduced every year as local manufacturing capability matures. It is important, that the list is consistently and uniformly applied to all public

procurement, including central, autonomous healthcare institutions and state-level procurement in all forms, including tender based or GEM portal-based procurement or PPP projects as a mandate. Such prioritisation will enhance investments in domestic manufacturing.

Secondly, partnership with states is critical to ensure that domestically designed and manufactured medical technology enables wider access to quality care. Some states in India were offering rebates to healthcare facilities built in non-metro areas for buying medtech products, ensuring the development of healthcare infrastructure in access-restricted geographies.

Lastly, while we strengthen domestic manufacturing, it’s important that our products are at par with the global standards. This requires creating a regulatory policy ecosystem that encourages the check on quality while removing multilayered/multiplicity of roadblocks. This enhanced ease of doing business will encourage more manufacturers to invest in India, improving access to quality products, that are manufactured in India.

How local is GE HealthCare in the context of the Indian market?

Established in 1990, Wipro GE Healthcare, the Joint Venture (JV) between GE HealthCare, USA and Wipro Enterprises Limited, India is one of the most successful and longestrunning JVs in South Asia. We have been pioneers of localization with more than 30 products developed with our global network, sold in over 70 countries. With the largest install base of medical equipment in the region, we

have four manufacturing sites in Bengaluru (JVs with Wipro Enterprises Ltd. and Bharat Electronics Ltd.), the most recent being our ‘PLI Factory’ under the government’s Atmanirbhar Bharat initiative – emphasising Make in India for India and the world.

With access to healthcare at the center of our commitment to India, we have the highest coverage across the country. Our expansion in the country is also marked by a strong network of our partners. For instance, GenWorks - our network which endeavors to support healthcare providers in Tier II-IV towns. Today, we have a GenWorks person at a distance of 200 - 300 km from a customer, compared to the traditional 700-800 km in the past. We are aiming to be within 100 km of the customer in future.

We are also among the first healthcare companies to start healthcare technology R&D in India over three decades back - the largest R&D Center of GE HealthCare outside of USA. Our efforts have resulted in over 1100 filed patents and the successful delivery of 125+ innovations tailored to meet the unique demands of the Indian healthcare landscape. In addition to our R&D center in Bengaluru, we have Centers of Excellence (CoE) dedicated to Software Applications, Mobile Ultrasound, and Healthcare Digital Solutions to develop specialised solutions that cater to the unique demands of the Indian healthcare landscape.

What are the steps that will secure India’s position as a global medtech hub ensuring ‘Made in India’ products meet global quality standards?

Achieving the goal of reducing

EXPRESS HEALTHCARE

35

January 2024

HEALTHCARE TRACKER import dependency from 80 per cent to 50 per cent by 2030, in alignment with the Make in India and Make for India initiatives, all while maintaining stringent quality standards, demands a holistic strategy. Quality healthcare, emphasising effectiveness, safety, and patient-centricity, is paramount to meet global quality standards, as underscored by the World Health Organization (WHO).

To position India as a global medtech hub and curtail import dependency, it is imperative to institute conducive regulatory environment that nurtures innovation and competitiveness. We need to have local standards that govern the design, manufacturing and sale of medical technology.

Simultaneously, to enhance export competitiveness we need harmonisation of the local standards with global standards. This allows manufacturers to participate in the large and growing local market but also compete in an even larger export market.

Why is India an important market for GE HealthCare?

Where does India stand today in terms of revenue in GE HealthCare's top 10 countries, and where do you expect India to be in the next 5 years, given India's focus on the Make in India theme?

Not only is India the fastest growing economy in the world but also the fastest growing market for GE HealthCare, globally. We are witnessing a dynamic change in the policy ecosystem, underlined by the

recent release of the NMDP 2023. Today, India is at the cusp of a transformative shift in the medtech sector with the world looking at the country as a promising investment hub.

Over the decades, Wipro GE Healthcare has strengthened the ‘Make in India’ journey by designing and producing medical technology solutions tailored not only for India but also for global markets. Of the total sales done, 45 per cent is based on locally manufactured products. A significant share of our diagnostic cardiology products is now manufactured within India. Notably, all our affordable care products in the Maternal & Infant care segment are conceived, developed, and manufactured in India, further cementing

our commitment to contributing to India's healthcare ecosystem while aligning with the nation's ambitious ‘Make in India’ vision. In the coming years, with significant investments, we will continue to deepen our commitment to bridging the healthcare gaps in India advancing patient centricity and partnering to the National healthcare agenda.

Does India's focus on domestic medtech make the country a less attractive market (when we talk a span of say next decade)?

India has a vast population with desire for high quality healthcare, improving penetration of health insurance, and rapidly developing healthcare system. There will be robust

demand for medtech products. The focus on domestic medtech manufacturing will drive adoption of medtech products creating a tailwind for the market. With such tailwind for the overall industry, nurturing robust domestic medtech industry will help meet India’s healthcare needs more efficiently and make the industry a competitive exporter of medical devices.

This dual advantage makes India an attractive market for both domestic and international players, fostering innovation and creating opportunities for collaboration. With the right strategies and regulatory support, India's emphasis on domestic medtech can strengthen its position in the global market.

IVcannulation: Revolutionising the way medication is provided to patients Satish Yadav, Manager- Sales & Marketing, Ami Polymer Pvt. Ltd throws light on the advantages of IV cannula tubes

T

he word pandemic has been the most petrifying word since the inception of COVID-19, in fact it has changed the perspective of the world towards healthcare.

Thanks to ever changing and advancing techniques and technologies in the healthcare, one such advancement has revolutionised the way medication is being provided to patient i.e., Intravenous (IV) cannulation.

Modern anaesthetists rely on the intravenous route for administration of drugs and fluids.

IV cannulation is a technique in which a cannula is placed inside a vein to provide venous access.

Venous access allows sampling of blood, as well as administration of fluids, medications, parenteral nutrition.

These are basically three types 1. Peripheral IV Cannula 2. Central IV Cannula 3. Midline Catheter Though there are various

36 EXPRESS HEALTHCARE January 2024

parts in IV Cannula but in this article we will adhere to one such part i.e., Silicone Non-returnable (NRV) tubing which has one of the most important and critical role in IV Cannula.

The tubing is designed for Nonreturnable valve application it requires high precision and

high quality. NRV silicone tubing has superior mechanical properties and elasticity that ensure a smoother operation.

via other routes 4. Medication Can be provided to patient even when patient cannot consume drug directly Ami Polymer Pvt. Ltd. is one of the most eminent player when it comes to Silicone tubing and other silicone product for Pharma and Med-

Advantages: 1. Immediate effect 2. Control over rate of flow 3. Avoiding absorption of drugs

ical Industry with the expertise of more than 25 years.

APPL offers a variety of the tubing dimensions specially

designed for different IV Cannula with high consistency and quality. There are several sizes of intravenous cannulas, the most common sizes range from 14 to 22 Gauge.

We take pride that Ami polymer has included the “Medical Product- IV cannula Non-returnable valve (NRV) tube” into its Portfolio with various range of size and smooth texture and obviously the design of its own which will bring drastic change in Medical Device Market. Ami polymer with its more than two decades of silicone expertise has manufactured a Silicone tubing’s in ISO Class 10000 Cleanroom for providing a best solution for the seekers who trust us with their Health and safety on line. Silicone tubing for IV Cannula from Ami Polymer meets all the certification requirement of various regulatory bodies.

HEALTHCARE TRACKER

Polymed's evolution: Pioneering healthcare through manufacturing excellence, innovation and sustainability Rishi Baid, Joint Managing Director, Poly Medicure Ltd. highlights that in a bold stride towards excellence, Polymed has expanded its manufacturing footprint, a testament to our dedication to meeting the surging demand for high-quality medical solutions

A

s we navigate the everevolving healthcare landscape, Polymed stands at the forefront of groundbreaking developments, showcasing a profound commitment to advancing healthcare solutions for a better and sustainable future.

In a bold stride towards excellence, the company has expanded its manufacturing footprint, a testament to our dedication to meeting the surging demand for high-quality medical solutions. We are delighted to unveil the addition of 3 state-of-the-art facilities in Faridabad and 1 in Jaipur, bringing our total manufacturing units to an impressive 12.

This expansion is not merely a numerical increase; it is a strategic move to enhance our production capacity and meet the evolving needs of the healthcare industry. These ultra-modern facilities are equipped with cutting-edge technology and adhere to the highest standards of quality and safety.

At the core of Polymed's success lies our steadfast commitment to innovation, encapsulated in our mantra, "Innovate to Dominate." The company’s unwavering focus on R&D has resulted in an astounding 370 patents & positioning. This dedication to continuous improvement and groundbreaking advancements positions us as leaders in the healthcare sector.

Innovation is not just a goal; it's a culture diligently nurtured. Our R&D efforts are driven by a passion to push the boundaries of what is possible

in healthcare. We believe that staying at the forefront of technology and medical science is not only a responsibility but a commitment to our mission of providing superior healthcare solutions.

Our leadership team understands that true success is not solely measured by financial achievements but also by the positive impact we have on individuals and communities.

Everything we do at Polymed revolves around the purpose of doing good for good well-being.

By aligning leadership with purpose, we create a culture that fosters ethical decisionmaking, compassionate leader-

ship, and a commitment to societal well-being. Our purposedriven approach ensures that our actions contribute positively to the healthcare ecosystem and beyond.

Polymed recognises that our impact extends beyond the confines of our manufacturing units. As part of our commitment to Environmental, Social, and Governance (ESG) goals, we have placed sustainability at the core of our operations.

Every decision, every process, is made with a consciousness of its environmental and social implications.

Moreover, our dedication to the well-being of the communi-

ties we serve goes beyond a mere corporate obligation. It is a reflection of our values and a recognition of our interconnectedness with society. We actively engage in initiatives that uplift and support local communities, fostering a symbiotic relationship that goes beyond the traditional boundaries of corporate social responsibility.

Our holistic sustainability approach is not a mere checklist of actions but a comprehensive philosophy that permeates our organisational culture. It signifies a commitment to creating positive and lasting impacts on the environment, society, and the communities we touch.

As we stand at the cusp of a transformative era in healthcare, Polymed embraces an innovation-driven culture. The future is driven by innovation, and we are prepared to lead the way. In our quest to stay ahead, we leverage modern tech platforms in every facet of our operations.

From refining our manufacturing processes to optimising supply chain management, we integrate cutting-edge technologies to elevate efficiency, precision, and accessibility.

This forward-looking approach positions us as pioneers, shaping the future of healthcare

through a commitment to innovation.

We firmly believe in the immense value they bring to our organisation, recognising each individual as a unique and essential contributor to our success. In cultivating a culture of growth and development, we place a strong emphasis on nurturing our internal talent across various facets of the business. Through comprehensive training programs, mentorship initiatives, and continuous learning opportunities, we aim to foster a workforce that is not only adept in their specific roles but also well-versed in the intricacies of our overall operations. This holistic approach not only fortifies our workforce but also ensures that our people are well-prepared to navigate the complexities of our industry, contributing to the sustained growth and success of the organisation.

Polymed's recent expansion, focus on innovation, dedication to sustainability, and purpose-driven leadership collectively reinforce our position as trailblazers in the healthcare industry. We are strived to continue our journey of innovation, sustainability, and commitment to a healthier and more prosperous world.

EXPRESS HEALTHCARE

37

January 2024

HEALTHCARE TRACKER

From integration of healthcare ITto advancements in the medtech sector,the industry is on a path towards a transformative journey Sunil Khurana, CEO & MD, BPL Medical Technologies shares that medical technology sector is shifting with the emergence of innovative devices

A

s we enter into the promising year of 2024, the healthcare sector finds itself at the forefront of innovation and evolution.

From integration of healthcare IT to advancements in the medtech sector, the industry is on a path towards a transformative journey.

extend their reach to patients in rural locations, contributing to prompt intervention in patient care.

Advancements in radiology and imaging technologies

Exploring possibilities in the medical technology sector The medical technology sector is shifting with the emergence of innovative devices aimed at providing patients with personalised and remote patient care. Medical devices such as blood pressure trackers are evolving into health monitoring tools. Understanding this importance of seamless connectivity, BPL home care devices are often equipped with smart features, allowing users to track and share their data with their healthcare providers.

This connectivity enhances remote monitoring capabilities, facilitating timely interventions as and when necessary.

Potential of telemedicine Telemedicine is yet another area witnessing promising growth in the coming years. In line with the commitment to innovation, BPL Medical Technologies is actively exploring its potential to incorporate these advantages into their medical devices. The integration of telehealth features in their medical equipment is a strategic step towards overcoming geographical barriers to make healthcare accessible. With the use of such medical devices, healthcare professionals can

38 EXPRESS HEALTHCARE January 2024

While these advancements bring immense promises, they also come with their set of challenges.

Interoperability, data security and healthcare accessibility are some of the pressing issues.

Additionally, the rate at which medical technology is advancing calls for ongoing training and education for healthcare professionals at every step

Radiology and imaging technologies are rapidly advancing, delving beyond surfacelevel diagnostics.

BPL Medical Technologies understands the evolving needs of healthcare professionals and is at the forefront of investing in cutting-edge imaging technologies. Their wide range of solutions under digital X-rays, ultrasounds as well as CArms provide healthcare professionals with crystal clear output and superior diagnostic capabilities. BPL digital Xray solutions employ advanced technologies for clear and detailed diagnostic images with reduced radiation exposure. BPL ultrasound systems feature cutting-edge capabilities, including 3D/4D imaging, deep analysis and much more, empowering healthcare professionals to conduct comprehensive examinations. Additionally, BPL C-Arms provide real-time visualization for precise guidance in various medical procedures, enhancing procedural efficiency and patient outcomes.

Digital healthcare The digital transformation of healthcare is no longer a distant vision—it is a reality that is rapidly unfolding. Healthcare IT plays a pivotal role in streamlining processes, improving communication, and enhancing patient outcomes.

BPL Medical Technologies recognizes the significance of

investing in robust healthcare IT solutions to facilitate seamless information exchange, ensuring that healthcare providers can deliver optimal care in an increasingly interconnected world.

Possible challenges and opportunities While these advancements bring immense promises, they also come with their set of challenges. Interoperability, data security and healthcare accessibility are some of the pressing issues. Additionally, the rate at which medical technology is advancing calls for ongoing training and education for healthcare professionals at every step. As an Indian brand, BPL MedTech understands the degree of it in the country, addressing specific challenges and requirements specifically in the Indian healthcare landscape.

The “Make In India” approach allows BPL MedTech to design and develop medical technologies that are not only cutting-edge but also culturally and contextually relevant.

In conclusion, the healthcare sector is on the cusp of a transformative era, driven by innovation, technology, and a commitment to patient wellbeing. BPL Medical Technologies is proud to be a part of this journey, contributing to the narrative of a healthier and more connected world.

As we embrace the challenges and opportunities ahead, the collaborative efforts of the government, healthcare providers, technology innovators, and industry stakeholders will undoubtedly pave the way for a brighter and healthier future.

HEALTHCARE TRACKER

Clinical chemistry Indian market is continuously growing Shobhit Jain, Sr. Manager, Product-Clinical Chemistry, Urinalysis, Marketing Events And Branding Marketing, Sysmex talks about the trends in clinical chemistry market in India

C

linical chemistry Indian market is continuously growing since last few years and will keep the pace in future too as there are increasing healthcare awareness, Acquisition and mergers, introduction of new tests, growth in non-communicable disease and chronic disease, aging population, increase focus on preventive medicine, preference for evidence based treatment, Increasing insurance cover, increasing number of life style diseases, Government’s initiatives & spending on healthcare, improving healthcare infrastructure and Accreditation.

The biochemistry market in India was the second largest

segment Indian IVD and In 2022, the Indian biochemistry instruments and reagents market is estimated at Rs 2699 crore, with reagents continuing to dominate at Rs 2220 crore at 83-per cent market share. This is an 11-per cent increase by value and a 17-per cent increase by quantity, over 2021.

Momentum in sales is expected to be maintained for next five years.

Demand for the fully automation biochemistry analyser and good quality clinical chemistry reagents has risen as present trend is to make laboratories more quality conscious by seeking Accreditations like NABL (National

Accreditation Board for Testing and Calibration Laboratories) and once these norms are followed, one can be assured of the quality of reports. So, under NABL norms the demand for biochemistry instruments is growing, as labs are required

to have a back up instrument ready.

Sysmex is committed to the Mission “shaping the advancement of healthcare” and continuously providing total diagnostic solution in Haematology, Haemostasis, Urinalysis, Immunoassay, flowcytometry, life science and clinical chemistry with the presence in more than 150 countries. Sysmex is the market leader in Haematology, Coagulation & Urinalysis automation worldwide and now started to facilitate growing clinical chemistry market as well.

For Clinical chemistry reagents and Instruments, Symex has introduced BX se-

ries fully automated clinical chemistry analysers including BX3010 & BX4000 for low end and mid end workloads with state of the art technology.

BX3010 has a unique ability to perform onboard hemolysing for HbA1c testing which eliminates pre analytical variables (Human & Pipetting) for sample pretreatment. BX3010 & BX 4000 has clot detection in sample arm, crash detection and liquid level sensing in reagent/sample arm, 5 speed mixing and pre cooled reagent carrousel which facilitate to avoid carry over, high reagent stability, generate high quality results and made it to true walk away system.

Medikabazaar introduces United Imaging's 5TJupiter It is the world’s first whole-body ultra-high field 5T MRI to revolutionise medical imaging in India

M

edikabazaar has announced the launch of United Imaging's 5T Jupiter in India. The world's first whole-body ultrahigh field 5.0T MRI, the uMR Jupiter 5.0T, was unveiled for the first time internationally along with United Imaging Healthcare's comprehensive flagship products across all modalities, including PET/CT, PET/MR, MR, CT, and DR. This MRI system promises to redefine medical imaging technology in the country, revolutionizing diagnostic capabilities and patient care.

The 5T Jupiter is equipped with a 5-tesla magnet, delivering exceptional image quality for precise diagnoses, even in complex cases. Its ultra-high field imaging capabilities allow detailed visualisation of the human body, aiding accurate evaluations. Powered by AI technology, this MRI system streamlines workflows and enhances diagnostic accuracy. Adaptive imaging tech-

niques optimise image quality while ensuring patient comfort during scans.

Let's delve into some of the remarkable features that set this MRI system apart: ◆ Unprecedented magnet strength: The 5T Jupiter boasts a colossal 5-tesla magnet, delivering unparalleled image quality and precision in diagnostics. This exceptional magnet strength allows for enhanced imaging of intricate anatomical structures with exceptional clarity, enabling accurate diagnoses even in the most challenging cases ◆ Ultra-high field imaging: Leveraging the power of a 5tesla magnet, this MRI system provides ultra-high field imaging capabilities. It enables radiologists and clinicians to visualise minute details within the human body, leading to more accurate and comprehensive evaluations of various medical conditions.

◆ Artificial Intelligence (AI)-powered imaging solutions: United Imaging has integrated cutting-edge AI technology into the 5T Jupiter, empowering radiologists with advanced tools for image reconstruction, analysis, and interpretation. This AI-driven approach streamlines workflows, reduces scan times, and enhances diagnostic accuracy, ultimately benefiting both healthcare providers and patients. ◆ Adaptive imaging techniques: The system features adaptive imaging techniques that automatically adjust to patient-specific characteristics, optimising image quality while minimising scan times.

This not only improves patient comfort during examinations but also ensures efficient use of healthcare resources. ◆ Comprehensive applications: From neuroimaging and musculoskeletal imaging to cardiac and oncologic im-

aging, the 5T Jupiter caters to a wide spectrum of clinical applications. Its versatility allows healthcare professionals to perform various specialised imaging studies with exceptional clarity and detail. ◆ Patient-centric design: United Imaging has prioritised patient comfort and experience in the design of the 5T Jupiter. The system's ergonomic design, reduced noise levels, and faster scan times contribute to a more comfortable and less intimidating MRI experience for patients, particularly those who may experience anxiety during imaging procedures.

Medikabazaar's collaboration with United Imaging to bring the 5T Jupiter to the Indian healthcare landscape marks a significant stride towards advancing diagnostic capabilities. By introducing this state-of-the-art MRI system, Medikabazaar aims to empower healthcare

providers with innovative technology that enables precise and timely diagnoses, ultimately improving patient outcomes.

The integration of United Imaging's 5T Jupiter into the Indian healthcare infrastructure through Medikabazaar signifies a commitment to leveraging cutting-edge technology for the betterment of healthcare delivery in the country. As this exceptional MRI system becomes more accessible, it holds the promise of transforming the diagnostic landscape, driving advancements in medical imaging, and positively impacting patient care across India.

The launch of United Imaging's 5T Jupiter by Medikabazaar heralds a new era of advanced medical imaging in India, where precision, innovation, and patient-centric care converge to elevate the standards of healthcare delivery.

EXPRESS HEALTHCARE

39

January 2024

HEALTHCARE TRACKER

Maximising the potential of connected technology in healthcare Shalin Patel, Managing Director, Draeger India Group stresses that connected medical devices have evolved from mere monitoring devices to dynamic sources of information, providing a comprehensive view of a patient's vital signs

I

n an era where healthcare providers grapple with the challenge of attracting and retaining qualified personnel amid escalating care demands, connected medical devices and data takes center stage, reshaping the landscape of patient care. Imagine decision-supporting technologies coming to the forefront, empowering healthcare professionals with real-time insights.

Envision remote control capabilities and automated processes seamlessly integrated into the fabric of highstakes healthcare scenarios.

At Draeger, one of such crowning achievements has been the launch of our pioneering ISO/IEEE 11073 #SDC conformant system— the Access and Control Package. This groundbreaking system represents a quantum leap in patient surveillance and remote control, a testament to our dedication to enhancing data availability precisely at the point of care.

Multi-faceted potential of connected devices Connected medical devices have evolved from mere monitoring devices to dynamic sources of information, providing a comprehensive view of a patient's vital signs.

Draeger offers a suite of databased applications designed to revolutionise hospital workflows. An especially interesting solution is the device utilisation analytics function, that compiles a wealth of information about the usage of networked devices. It facilitates seamless monitoring of live device statuses, reviews of devices' usage history, and examinations of the latest software statuses—a comprehensive approach to maximising the potential of medical technol-

40 EXPRESS HEALTHCARE January 2024

Draeger offers a suite of data-based applications designed to revolutionise hospital workflows ogy. Another perpetual challenge faced by hospitals is in optimising clinical workflows.

The inefficiencies prevalent today contribute to increased

risks of errors and potential burnouts among dedicated staff. Our OR Companion application is a game-changer that provides a centralised

overview of the status information of all networked anesthesia devices. It ensures swift and effective monitoring across all operating rooms.

The significance of interoperability standards in acute care cannot be overstated. Beyond streamlining current use cases, such as the documentation of vital data, these standards pave the way for secure alarm management and remote device control. Its potential in scenarios like isolation rooms and telemedicine, where seamless interoperability becomes the linchpin of efficient and effective care delivery. For instance, the relentless and often unnecessary use of alarms in Intensive Care Units (ICUs) has become a major contributor to the pervasive issue of excessive noise levels. The array of equipment deployed in ICUs, including patient monitors, ventilators, and infusion pumps, generates a multitude of technical and clinical alarms, with up to 8595 per cent being false positives. This prevalence of false alarms not only contributes to alarm fatigue among clinical staff but also poses a significant risk, as important alerts may be overlooked, resulting in delayed or missed interventions with potential serious consequences for patients.

The repercussions of high noise levels in ICUs are manifold, contributing to delirium, increased pain, and prolonged hospital stays. Considering these challenges, it is vital to address noise levels in ICUs to enhance patient outcomes and create a safer and more comfortable environment for patients, their families, and healthcare providers. An essential component of a comprehensive alarm management strategy is alarm

analytics, which involves retrieving data from medical devices to assess alarm occurrences. By identifying the root causes of excessive alarms, healthcare providers can develop effective strategies to significantly reduce the number of clinically irrelevant alarms. Solutions like Dräger Alarm History Analytics exemplify the potential of comprehensive alarm analysis, providing valuable insights into clinical alarms and paving the way for a quieter and more efficient ICU environment.

Revolutionising patient care with interoperability Interoperability emerges as a key solution in tackling such issues by facilitating the integration and communication between diverse medical devices and information systems. By harnessing the power of interoperability, we can not only simplify existing processes but also open doors to entirely new concepts of care-delivery. Machine-learned automation of therapies, a concept that goes beyond traditional boundaries, are propelling us into an era where technology becomes a true ally for better patient outcomes.

The healthcare industry is at a juncture where addressing the connectivity gap is not a choice but an imperative.

Draeger remains agile in responding these evolving needs. We understand that it isn't merely about technological innovation; it's about seizing the full potential of these innovations to create tangible, positive outcomes for both patients and healthcare professionals alike. Draeger stands committed to driving positive change and ushering in a new era of connected and compassionate healthcare.

Intelligent healthcare made easy

PRISM Edition Innovate. Illuminate. Initiate.

Powered by three Canon Medical Altivity brand technologies — Precise IQ Engine (PIQE), Advanced intelligent Clear-IQ Engine (AiCE), and Deep Learning Spectral Reconstruction — Aquilion ONE / PRISM Edition is designed for deep intelligence.

Advanced intelligent Clear-IQ Engine (AiCE)

https://global.medical.canon/ Learn more about Aquilion ONE PRISM Edition

©Canon Medical Systems Corporation 2022. All rights reserved.

Please contact your local sales representative to learn more.

ERBIS ENGINEERING COMPANY LIMITED 39 Second Main Road, Raja Annamalaipuram, Chennai - 600 028. Tel:044 42961400 Mail ID : info@erbismedical.com

! " # $

REGD. WITH RNI NO. MAHENG/2007/22045, POSTAL REGD. NO. MCS/162/2022 – 24, PUBLISHED ON 8TH EVERY MONTH, POSTED ON 14TH, 15TH, 16TH EVERY MONTH, POSTED AT MUMBAI PATRIKA CHANNEL SORTING OFFICE, MUMBAI – 400001